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Abstract 
With the completion of the Human Genome project, advances in bioinformatics, 
computational biology and scientific techniques, human genetic research has established 
itself as a leading focus of study for many involved in the biological research world. However 
with all forms of research comes the relevant ethical procedure to guide these studies. Human 
genetic studies are especially intricate in their ethics evaluations as not only do they require 
biological material to be obtained from an individual or group of individuals but it in turns 
gives a researcher access to one’s own personal genetic code, i.e. DNA sequence. Such 
information has become extremely useful in identifying predispositions and causative factors 
for certain diseases, identifying possible phenotypic traits, clues into one’s ancestry as well as 
the overall potential for commercial gain by pharmaceutical companies in drug and gene 
therapy research and development through acts of gene patenting. Thus with the biological 
world completely open to exploitation, the need for various control regulations and guidelines 
to be further developed to address these issues persists. The main questions addressed in 
studies such as these are those of ownership - who does the sample belong to - access and 
benefit sharing should any product be developed from information gathered from these 
samples, consent for use of these samples outside its intended purpose as well as protection of 
vulnerable groups for unique genetics studies. There are four main sections in this report. 
First the concepts of Genomic Sovereignty and Common heritage are discussed. Following 
this, some philosophical theories of ownership are investigated to provide justification toward 
the concept of ownership with regard to the human body and international bioethical 
guidelines are then discussed with regard to research involving samples of human genetic 
material from population groups. The third section is an analysis of the law with regard to 
ownership, patenting and benefit sharing from research using human genetic material. The 
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fourth section synthesizes the information of the previous 3 sections to produce an alternate 
approach in dealing with research involving human genetic material from population groups. 
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1. Introduction 
 
The study of human genomic diversity is nothing new to the world of science. From the days 
of Darwin to Mendel and even today, scientists all around the world are constantly seeking 
the scientific quest to find the answers that lay in our DNA
1
. Some of these include 
determining which among the many populations around the world is the oldest, tracking 
human evolution as well as searching for causative agents in one’s genes that cause or 
predispose oneself to certain diseases and disorders
1,2
. The valued effort to provide the 
scientific community with the complete sequence of the human genome has led to an even 
greater influx of research into the questions mentioned above.  
The complete sequencing in 2003 of the human genome, funded by the US Department of 
Energy and the National Institutes of Health
1
, came with the hope of establishing new 
information and links between the estimated 20 000 – 25000 genes and how their 
malfunction/ mutational events can cause disease
1
. An overview of post human genome 
project possibilities into disease prediction and improving their related therapeutic 
interventions are found on the website.  
The ultimate goal is to use this information to develop new ways to treat, cure, or even 
prevent the thousands of diseases that afflict humankind. But the road from gene 
identification to effective treatments is long and fraught with challenges. In the meantime, 
biotechnology companies are racing ahead with commercialization by designing 
diagnostic tests to detect errant genes in people suspected of having particular diseases or 
of being at risk for developing them.
1 
 
While studies into these various research areas has provided us with immense understanding 
into who we think we are and what we are capable off, recently questions have arisen as to 
how this type of population based genomic research is being undertaken. Much discourse 
around this topic relates to the manner in which samples are attained, who controls what 
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happens to these samples, where research is done, who is involved and what the benefits and 
access to these studies are there to the populations involved.  
The purpose of this research is therefore to examine the ethical and legal issues that should be 
considered by researchers before, during and after the commencement of genetic research. 
The paper deals primarily with the ethical and legal concerns regarding the nature of 
ownership that should be determined before bodily samples/DNA can be collected from 
specific groups or populations through analysis using two concepts, namely Genomic 
Sovereignty and the Common Heritage concept. 
1.1 Genetic background 
 
Since the complete sequencing of the human genome and the discovery that human beings of 
all ethnic backgrounds share ~99.9% of their genomic sequence with one another, the need 
for individual research has become somewhat phased out with the second phase of mapping 
known as genome-wide association studies (GWAS) coming into focus
3
. Thus moving away 
from the traditional Mendelian approach, which dealt primarily with single gene disorders, 
scientists and researchers are now able to look deeper into the ways in which genes interact 
with each other as well as the influence of environmental factors in disease phenotypes. But 
sequencing a whole human genome whilst being knowledgeable of the vast similarities 
between all individuals would be scientifically wasteful of both time and resources, hence a 
faster method to analyse the 0.1% variation in all populations needed to be established. This 
resulted in the formation of the HapMap initiative in 2002
4
, which uses Single Nucleotide 
Polymorphisms (SNPs) as markers for genetic variants associated with a disease in question. 
These SNPs are then grouped together to form haplotypes.  
A haplotype can be defined as ‘a set of DNA variation or polymorphisms that tend to be 
inherited together’ on a region of a chromosome that is not commonly altered by 
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recombination events such that they are highly conserved regions on a chromosome that one 
can use as a genetic marker
4
. These haplotypes can span large regions of a chromosome such 
that the in-between regions are capable of recombination events.  
The HapMap project then makes use of these SNPs by producing catalogues of linked 
variants for disease profile associations thus making analysis for specific diseases or 
phenotypes easier and quicker to research. This reduces the amount of time spent on such 
research, leading to a more rapid increase in the knowledgebase as well as making such 
genomic research endeavours more cost-effective
4
. For the HapMap project to be sustainable 
it required samples be collected from individuals of different ancestry, namely, Asian, 
European and African. The project has gained much popularity in providing a well-informed 
database for those involved in genomic research as well as pharmaceutical research and 
development with specific interests in personalised medicine. However some controversies 
have arisen in relation to the means in which populations were engaged, consent obtained and 
the manner in which these individuals were defined during sample collection.   
In response to the issues above mentioned, the emergence of the concept of genomic 
sovereignty has been brought to light. 
1.2 Defining the concepts 
 
In this chapter the concepts of Genomic Sovereignty and Common Heritage will be defined 
and discussed. The aim of this section is to provide an overall understanding of how these 
two concepts are related to ownership of human genetic material as well as providing 
background information into each concept with regard to their origination, significance and 
use in issues relating to ownership from an ethical as well as a legal perspective. 
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Genomic Sovereignty is a concept described as “the capacity of a people, country or nation to 
own, to control both access and use of samples, data and knowledge emanating from genetic 
material”.5(p436) The definition stems from a reaction to a statement made in 1997 by the 
United Nations Educational, Scientific and Cultural Organisation (UNESCO)
6
 which 
declared the human genome “the heritage to humanity”. The UNESCO statement has been 
subjected to both severe criticism on the grounds of ‘bio-colonialism’ or ‘genetic piracy’5 as 
well as support on the grounds of the ‘Common Heritage Concept’. 
Bio-colonialism refers to “the unpermissioned appropriation or exploitation of indigenous 
peoples’ genetic resources, traditional-medical or ceremonial-knowledge or cultural and 
human rights by practitioners of the new biotechnology”7. Bio-piracy refers to “the practise 
of commercially exploiting naturally occurring biochemical and genetic material, especially 
by obtaining patents that restrict its future use, while failing to pay fair compensation to the 
community from which it originates”.8 
Proponents of genomic sovereignty attempt to dispel such negative views of bio-colonialism 
by advocating that through some form of national/local regulation, misappropriation, 
exploitation and social justice can be acted upon with greater vigour and strength owing to 
national protective measures that aim to protect its people
5
 as well as secure some amount of 
benefits for the people or community contributing their biological samples. It is therefore 
assumed that those who advocate for the concept of genomic sovereignty base their 
supporting argument on having a level of structure to control how genetic research is 
conducted on a people, nation or state. Providing a guideline as to how such research should 
be undertaken within a community therefore ensures that benefits of a study and a certain 
amount of economic gain is rightly awarded to the contributing community.  
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Contrastingly, proponents of the common heritage concept welcome UNESCO’s declaration 
with regard to the human genome. Those who advocate for the common heritage of the 
human genome do so with the vision that all knowledge should be shared and that, for 
genetics/genomics, the fact that we share the same DNA from one human being to another 
makes us connected to each other
9
 through genetic heritage and linked to each other through 
genetic diversity. It is likely that common heritage supporters would suggest that the sharing 
of knowledge between one another should be considered a kind of global 
communitarianism
23
, from which the donation of genetic material for research purposes 
should be altruistic in nature. The common heritage concept therefore debases the notion of 
bio-colonialism and bio(genetic)-piracy and instead promotes the creation of open source 
platforms for all to be able to obtain genetic/genomic information and therefore use it freely 
in research.
23
 Overall the common heritage concept promotes the idea that makes ownership 
of any genetic material a universally applied rule, such that it is owned by everyone in the 
world. However this does not imply that one may have an ownership right over any other 
person but themselves. 
As shown the concepts of genomic sovereignty and the common heritage bring to light 
seemingly opposing frameworks from which to consider the ownership of genetic material, 
data and knowledge. Ownership is an important issue which requires resolution in terms of its 
ethical dimensions in order to provide grounds upon which the law regarding ownership can 
be clarified. 
1.2.1 Defining Genomic Sovereignty 
 
The term genomic sovereignty was coined by Mexican legislators as a means to ensure 
ownership over Mexican human genetic resources as well as to stifle the growing concerns of 
bioprospecting of these human genomic resources by foreign entities based on the premise 
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that such resources and their related data hold both significant and commercial value.
10
 The 
concept of genomic sovereignty aims to protect the genomic material of a nation, state or 
people; in doing so, those belonging to that land or who fall within its boundary lines are 
presumed to be protected from bioprospecting and bio-piracy as well as encouraging benefit 
sharing. Furthermore, by implementing a level of protection over genetic material it in turn 
provides a platform for better co-operation between a research body and the nation state. 
An example of a sovereign claim to genetic material is that of the lawsuit of the Havasupai 
Indian tribe V Arizona State University, over improper research use of DNA from that 
community
11
. The research study was initially done in efforts to search for a genetic variant 
that might be a contributing factor to the increasing rate of diabetes in the Havasupai people. 
Consent was obtained prior to collection of the samples of the initial study on diabetes 
research. At the end of the study, DNA and blood samples still in possession of that state 
university was used without consent of the Havasupai people in other genetic studies such as 
schizophrenia, ancestry and inbreeding. Upon the Havasupai discovering what other studies 
the university had used their peoples DNA for, the tribe filed a lawsuit against the state 
university for improper use of DNA from members of the tribe. The six year case was 
eventually settled in April 2010.
11
 The settlement included $700 000 in compensation to the 
Havasupai tribal members, funds for a clinic and school and the return of the DNA samples 
to the tribe. 
Although the lawsuit was based on improper use of DNA from the tribe and lack of fully 
informed consent, the final verdict which ordered that the state university return the DNA 
samples to the tribe exhibits a form of ownership in which sovereignty over genetic material 
was claimed by the Havasupai tribe. By claiming their genetic heritage as sovereign, they 
therefore are able to claim ownership and control over the use of such biological material as 
well as dictate the conditions under which such samples can be utilised. The misinterpretation 
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and failure to obtain fully informed consent from the Havasupai tribe with regard to the 
intended use of their genetic material can be seen as the causal factor from which genomic 
sovereignty and genetic heritage are able to control both access to and use of those samples, 
curbing bioprospecting. 
The concern that bioprospecting presents is particularly relevant in a sub-Saharan context, 
such that in sub-Saharan Africa, as well as much of the rest of Africa, genomic diversity has 
been relatively understudied, despite scientific evidence promoting the high proportion of 
human genetic diversity within the continent
12
. South Africa, in particular hosts a wealth of 
different population groups, such as the indigenous Khoi-San, Xhosa, Zulu, Venda, as well as 
the Afrikaners, Asians and Coloureds, the latter being a uniquely admixed population of 
immigrant Europeans, Asians and indigenous peoples
13. According to the ‘Out of Africa” 
hypothesis
14
, Sub-Saharan Africa is believed to be the area in which modern humans 
arose
14,15
. Thus the populations here are considered to hold in them a wealth of human 
genetic, linguistic and cultural diversity
14
. There is a lot
  
to be learnt from understanding and 
investigating human genetic variation from this part of Africa. 
Proponents of genomic sovereignty would argue that protecting these resources from bio-
piracy and bioprospecting enables South African researchers to maintain a competitive stake 
in the global genomic research arena, such that it allows developing countries such as South 
Africa the opportunity to leverage their ‘unique’ genomic variations within their respective 
population(s), so as to, “encourage local innovation and participate as equals in the global 
knowledge economy”16.  
In Mexico, Thailand and India, investment in genomic medicine has played a significant role 
in these nations participation in a global knowledge-based economy
13
. In South Africa the 
innovation within the biotechnology sector, which included genomics has started to develop, 
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insofar as to promote economic growth and stand firm as a formidable competitor in the 
global market
13
. 
Sustainability of economic growth through knowledge-based works is highlighted in South 
Africa’s Department of Science and Technology report entitled “Innovation toward a 
knowledge-based economy: Ten-year plan (2008-2018) for South Africa”17. The report 
highlights genomics as an economic investment, which South Africa should use so as to 
position itself as a “major producer in the pharmaceutical and nutraceutical industries through 
the development of appropriate technology platforms that would be based on local 
strengths”13(p599). However since the release of this report, South Africa currently still has no 
national genomic platform comparable to Mexico’s National Institute of Genomic Medicine 
(INMENGEN)
18
 with its focus on commercialization of locally generated knowledge. 
In countries such as South Africa, the potential to improve and build upon skilled resources 
are regarded with high importance as a necessity to build such skills locally
19
. It can be 
understood that research initiatives undertaken within local indigenous communities stand a 
better chance of community co-operation if the researchers involved in the study are native to 
that land. This would allow both compensation and dissemination of information to be 
executed much more efficiently. The National Biotechnology Advisory Committee’s 
(NBAC) position statement on genomic sovereignty in South Africa
20
 advocated the use of 
locally skilled individuals as well as locally developed resources as a fundamental component 
in retaining genetic/genomic material within the countries boarders. The statement although 
promoting local innovation, does not exclude such research being undertaken through 
collaborative partnerships with outside partners of that country thus promoting national 
research capacity.
19
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In summary proponents of genomic sovereignty would argue that it is an important concept 
which could play a role in ensuring that the benefits of the genomic research conducted using 
genetic material obtained from a specific people, nation or state would be more likely to 
accrue to that people, nation or state. Thus it would go some way in protecting developing 
countries from being exploited by developed countries in this field of research. 
1.2.2 Defining the Common Heritage Concept 
 
The first introduction of the common heritage concept (CHC) was during the 1960’s in an 
effort to regulate the material resources that were deemed to be of global responsibility, such 
as the ocean seabed, outer space, Antarctica and the moon.
21,22
 In the 1970’s the concept was 
then expanded to include culture and cultural heritage.
23
 This expansion lead to the 
formulation that the world and humanity itself is a global village, linked to each other through 
our history and ancestry
23
. Cultural heritage is expanded to beyond local cultures throughout 
the world so as to emphasise the cultural heritage that humanity overall exhibits thus making 
it common to all. Emphasising cultural togetherness promotes the need for global solidarity 
and management to protect and utilize certain property equally and with benefit to all.
23
  
In wasn’t until the late 1990’s that the concept of common heritage was uttered within the 
field of genetics
23
 followed shortly after in the 2000’s by global bioethical frameworks being 
drafted around the topic by organisations such as UNESCO
6
 for example. 
From a common heritage point of view, UNESCOs declaration of the human genome being 
“heritage to humanity” can be used as defence for preserving and equitably distributing this 
resource for the benefit of Mankind
6
. Heritage simply defined is provided as a “property that 
is or can be inherited – denoting or relating to things of architectural, historical, or natural 
value that are preserved for the nation” 24. The concept of common heritage for mankind has 
its foundation set in the doctrines Res communis, also referred to as Res communis 
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humanitatis
25
. The doctrine states that all human beings are members of the human race 
regardless of whether they live in the developed or developing world, and that “things” 
cannot be appropriated such that everyone should have access to its use. The use of a 
resource is allowed only if it is not held in monopoly or within exclusivity to one person or 
company insofar as one’s use for this resource should not impede its use for the next26. 
The common heritage concept, while pre-dating that of sovereign resources up until today 
continues to lack a universal definition among those of the ethical and legal world. However 
in its absence there are 5 principles that those of the legal fraternity propose as guides 
towards such definition.
21,22
  
The first is that there will be no private or public appropriation as the commons belongs to 
all; the second is that all nations should manage the resource since the ‘common’ belongs to 
all. Third, all nations should share in each others benefits acquired from exploitation of the 
common resource. The fourth principle refers to weaponry or military installation in a 
common area, however since the human genome cannot be delimited to a region or singular 
landmark, the fourth principle could be consider under the conditions of bioterrorism. Fifth, 
the commons should be preserved for the benefit of future generations, insofar as to prevent a 
“tragedy of the commons” scenario22. 
Following from UNESCO’s declaration that the human genome in its natural state should not 
give rise to financial gain
6
, the idea of common heritage in light of bio-piracy has been used 
as a defence against any patenting laws with regard to the human genome. Much of the 
common heritage concept has been used as a flagship in debates around DNA patenting and 
commercialisation. Whilst opponents to this concept attempt to prove that patenting and 
commercialisation in certain forms are morally acceptable, they still acknowledge 
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UNESCO’s statement of the human genome as ‘heritage to humanity’ but choose to view it 
as a symbolic rather than literal interpretation
27
. 
Maintaining some level of symbolism with regard to the human genome being considered a 
heritage to humanity allows for those who oppose the absolute literal interpretation to provide 
a means in which they can re-interpret its current understanding in an effort to sway 
opponents of the concept of genomic sovereignty to become more lenient to the idea. One 
such way may be to use the words “heritage to humanity” as a means of marketing by 
campaigning the potential idea that in protecting one’s genetic material, one’s genetic 
heritage is also protected and that to save humanity, one must start on home ground, so as to 
say that, if you protect your own and preserve your local heritage it in turn continues to 
maintain its valued position as a contributor to our overall heritage and all of humanity. 
However those who advocate for common heritage employ the notion that whatsoever 
findings in the form of diagnosis, therapeutics, or drug development that one might have 
should belong to all people and all nations. For example, the Convention on the Law of the 
Seas
28
 states that, “all rights in the resource of the area are vested in Mankind as a whole, on 
whose behalf the authority shall act”. 
The concept of common heritage within its doctrines has no explicit prohibitions that prevent 
economic exploitation of a common heritage resource.
9
 Therefore all resources that are 
declared to be a common heritage resource can be ‘mined’, such as the moon, sea bed and 
even the human genome. However the principles of common heritage stipulate that if such 
actions are undertaken on a resource regarded as common heritage, then “all nations and all 
peoples should still have access to that resource and be able to all share in the benefits 
derived from it”.28 
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By sharing both the resource as well as the benefits accrued from research involving genetic 
material, the acts of bio-colonialism and bio-piracy are diminished. From a socio-economic 
point of view, developing and low income countries are also able to gain from any benefits 
gained from a common heritage resource.
28
 This is especially important for developing 
countries where their indigenous peoples’ (genetic) knowledge has been subjected to acts of 
bio-piracy and safari research.
5
 The common heritage concept therefore provides a means 
through legal governance, a structure that promotes bidirectional flow,
28
 from those doing the 
research to those whose resources are being used, of knowledge, resources and technology 
transfers, thus ensuring that those who give, or rather provide biological genetic materials 
receive comparable benefits. 
Proponents of the CHC base their arguments on several standings, such as, the high degree of 
DNA sequence commonality between individuals and by extension associated populations
29
. 
In addition, genes are hereditary genomic blueprints of a population, or group of individuals 
that share a common ancestor (notion of the ‘Out of Africa Hypothesis’). Those who 
advocate for this concept appear to do so with the intention to stifle and seize acts of bio-
colonialism or bio-piracy
5
, insofar protecting genetic material capitalised on mainly by 
western developed countries while taking into account the technological disadvantage some 
developing countries, such as South Africa, may have. Thus many of these developing 
countries rely on the scientific capacity being aided by developed nations.
30
 
For example, GWAS requires access to laboratory facilities that are capable of processing 
large scale genotyping of the samples in the study, additionally there needs to be available the 
statistical expertise to aid in interpretation and analysis of the GWAS data produced. These 
necessities are only available in a limited number of countries, most being within the 
developed northern hemisphere nations.
30
 Thus samples for such studies are often exported to 
these sophisticated centres for processing, genotyping and statistical support.  
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For developing countries, who send their genetic samples to these institutions; the concern is 
raised that once the samples have left the country’s borders, control over its use is limited.30 
This plays into the notion of dual use for these samples, such that while the intended data will 
be obtained for the study purpose in the developing country, secondary use of those samples 
is possible outside the focus of the intended study by researchers in these sophisticated labs. 
The lack of control over samples in genetic research poses a key challenge for research on 
populations from the developing countries and builds a general lack of trust between the 
researcher and the population under investigation. For a country like South Africa, rich in 
genomic diversity within its populations, the situation isn’t very different. The study 
conducted by Sathar, Dhai and van der Linde
31
 investigated if researchers and a research 
ethics committee at a South African Institution addressed ethical issues pertaining to human 
biological materials in collaborative research with developing countries. Their findings 
indicated that “researchers and the Research Ethics Committee did not adequately address the 
inter-related ethical and regulatory issues pertaining to human biological materials and that 
there was a lack of congruence between ethical guidelines of developed countries [and] their 
actions which are central to the access to human biological materials in collaborative 
research. Human biological material may be leaving South Africa without export permits and 
material transfer agreements during the process of international collaborative research”.31 
Ownership of common heritage resources, including genetic/genomic materials, information 
and data, is seen as universal, such that every person on this world has a property interest in 
that resource.
27
 Common heritage in its entirety only considers benefits that should be 
accessed by everyone irrespective of whether you are from the developed or developing 
world. However the common heritage concept can be seen as being too broad in its approach 
with regard to its application to a common heritage resource and only completely applicable 
if defending such a resource against a foreign nation not of this world.  
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The common heritage concept does however suggest that governance on how a resource 
should be utilised and how the benefits be distributed, globally. It also provides legal 
governance with regard to those whom invest largely in research and development of a 
common resource in efforts to produce a product useful to all. The Convention on the Law of 
the Sea,
28
 which stands firm as the strongest example that, exemplifies the common heritage 
concept, calls for ‘equitable sharing of financial and other economic benefits’. This is 
executed through an international committee that includes a representative of every country. 
The issues of financial and other economic benefits are discussed and allocation of benefits 
decided upon based on a one-country-one-vote approach.
29
 
Alternatively, those who are opposed to the notion that the human genome be classified as 
common heritage propose that it be valued as a common resource rather. Arguments 
supporting the common resource ideology suggest that if the human genome is actually to be 
considered Mankind’s common heritage, then it implies that every human being, whether in 
acknowledgement or not, has an ownership interest in the genome.
27,32
 This would make it 
virtually impossible to gain consent for any genomic related research as every living human 
being would have to provide consent.
27 
Thus under Common Resource modelling, the 
understanding would be that research, patenting and commercialisation can be morally 
acceptable provided that moral duties toward such a resource are maintained. Such duties can 
be borrowed from Aldo Leopold’s Land Ethic33 which emphasises the duties of stewardship 
and justice. 
It is clear that these two concepts of Genomic Sovereignty and Common Heritage seem to 
present incompatible views with regard to ownership of genetic material with one claiming 
that it should belong to the nation or people from whom it came from and the other stating 
that the human genome is the common heritage of all and so the concept of sovereignty 
should not apply to it. 
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2. Ethical Framework associated with Genomic 
Research and Related issues of Ownership 
 
In this chapter various theories relating to ownership will be discussed. The purpose of this 
chapter is to present a link between the theories as well as explain, analyse and propose how 
ownership of genetic material can be associated to them. The theories outlined in this chapter 
include Kantianism, John Locke’s theory of ownership, and global bioethics with a 
communitarian approach in conjunction with African philosophy. The aim of this chapter is 
to formulate the philosophical underpinnings with regard to ownership that will later be used 
in relation to the concepts of genomic sovereignty and the common heritage concept. 
2.1 Understanding Ownership: Defining property 
 
Ownership by general understanding relates to the some form of property and by defining the 
level of ownership rights to property rules, can be created that govern access to and control of 
that property. Ownership of anything is to lay claim over some form of property, therefore by 
association ownership rights are considered analogous to property rights.
34
 
Ownership of property has 3 categories. These are common property, collective property and 
private property.
34
 In common property “resources are governed by rules whose point is to 
make them available for use by all or any members of society”. This type of property 
ownership allows for open access to resources, such as a street or park. Common property 
employs the notion of equal access and use of that resource, but places a restriction for its 
use. The restriction is to prevent any type of hoarding that might occur with use of that 
resource such that the use of that resource by one does not impede in its availability and use 
for another at the same time.
26,34
 Common property like a recreational parks are usually state 
controlled, that is, it is the responsibility of the state in which the common property exists to 
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maintain it for continued and future use. Collective property varies slightly from that of 
common property by advocating that “the community as a whole determines how important 
resources are used”.34 This type of ownership is decided upon through communal discussion 
and or debate. This can be either national or more local where by collective decision making 
is made by the people of that area, such as, the community chief or king, their cultural and 
spiritual leaders as well as regular members of the community. 
Overall common and collective property apart from the variation mentioned above share the 
same principle of ownership. Therefore due to the similarity between these two property 
types, these shall be jointly referred to as collective property throughout this section. 
Private property in contrast to collective property provides for the acquisition and 
autonomous rule of individual ownership over a resource.
34
 In this way a person is free to 
make decisions regarding the use, conditions for use as well as defining who may have access 
to the use of that resource. Based on this description, private property can be thought of as the 
key element of private ownership on which intellectual property rights are based, such as 
patenting. 
The rules of private property allow for decisions of self-interest to be made without the need 
for justification from the public.
34
 However even though one might hold private ownership of 
a property, that person is within limits only allowed to use that property. The most likely 
restriction or limitation to a privately owned resource would be that its use or destruction 
does not amount to any amount of maleficence to those outside private ownership of that 
resource.
34
 For example a person who owns a factory cannot decide to release harmful gases 
into the air from his company because air is breathed by everyone and this would endanger 
the lives of others. 
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In private ownership the right to reserve access and control of a resource can be prescribed by 
the owner.
34
 That person also has the option to trade that resource as a form of commodity 
such that he/she may sell the resource completely to another or even gift it to that person, in 
which case the new owner shall acquire all the controlling rights to that resource from its 
previous owner. Alternatively the owner may even allow a ‘buy-in’ of that private resource, 
making it a shared resource between a selected few.  
Overall the greatest contrast between collective property and private property is the 
restriction placed on each. Collective property affords everyone equal access to a resource 
provided one’s use of it does not impede on the next person. Private property on the other 
hand restricts access and use of a resource to only those who own it. Thus collective property 
from a philosophical point of view portrays a state of communitarianism displaying an 
altruistic nature, whereas private property embodies the principlistic nature of autonomy as 
well as rights based ethics with regard to personal freedoms, such as the freedom of choice. 
2.2 A philosophical overview of property and ownership 
 
Philosophical discourse surrounding the issues of property and ownership revolve between 
the self-interest of private property and communal value of collective ownership. For 
example, Plato argued in favour of collective ownership ideals, proposing that if property was 
collectively owned, everyone has a property interest in the resource, and that it would then 
create and maintain a form of social togetherness between people by each person sharing in a 
common interest.
34
 
Aristotle argues the opposite, advocating for private ownership on the basis that it promoted 
virtues like prudence and responsibility, stating that, ‘when everyone has a distinct interest, 
men will not complain of one another, and they will make more progress, because everyone 
will be attending to his own business’.35 Furthermore Aristotle takes on a counter-intuitive 
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approach with regard to altruism. While many might correlate being altruistic with striving to 
achieve a common good, Aristotle uses altruism as a means of drawing a parallel to that of 
one tending his own private property rather than questioning its acquisition by others. This is 
akin to ‘minding one’s own business’ whereby the common good to be achieved is not to 
intrude or interfere with the personal relationship between property and freedom of others 
and to have a sense of ownership over a thing  invokes a status of liberty, whereas to be 
owned is by nature to be owned by another. Aristotle portrays this using the concept of 
slavery of a person as an example.
34
 In this example, the slave loses his entitlement to self-
ownership as an autonomous being because it is claimed by another, to whom the slave owes 
servitude. Autonomy refers to the respect of an individual to make independent decisions and 
choices
36
. In western culture, the term denotes the boundaries of the singular, to put into 
context then the phrase ‘to each his own’ is apt.  
Aristotle’s example of the slave highlights the philosophical challenge with regard to self-
ownership. As embodied beings, believing that our spirit is linked to our bodies provides for 
an intimate pre-legal relationship to exist with our own bodies.
34
 We are therefore born with 
the freedom and senses to enable us to continue living our lives. Thus if our range of motion 
is restricted or limited we are then put in a position that renders us incapable of living a full 
life since control and/or manipulation of our bodies are regulated by someone other than 
ourselves. Self-ownership forms a discursive pattern that authors such as John Locke and 
Immanuel Kant have attempted to provide clarity on. 
2.3 Lockean theory of ownership 
The Lockean theory of ownership
37
 can be used as a form of justification for the right to 
private ownership to things that currently have no private owner. Locke argues that if one has 
a property in himself then he rightfully also has a property and by association ownership right 
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to his own labour, which he demonstrates using the example of private ownership over pieces 
of land that is common to all. In his theory, Locke imposes two restrictions in claiming 
private ownership
37
. The first is that there is ‘enough and as good’ left of that property for 
others to appropriate and the second restriction is the ‘spoilage limitation’, which stipulates 
that one should only take that which he is able to maintain and to sustain him without 
wastage, such as growing of vegetables and having too much for oneself that it spoils. 
Locke’s uses this theory of ownership not only for issues related to land but also towards the 
ownership of the human body. A passage from The Second Treatise on Government 
illustrates this, 
Though the earth and all inferior creatures be common to all men, yet every man has a property in his 
own person. This nobody has any right to but himself. The labour of his body, and the work of his 
hands, we may say, are properly his. Whatsoever then he removes out of the state that Nature hath 
provided, and left it in, he hath mixed his labour with, and joined to it something that is his own, and 
thereby makes it his property (Locke, 1978, p.130). 
 
And in the same book: 
 
From all which it is evident, that though the things of Nature are given in common, man (by being 
master of himself, and proprietor of his own person, and the actions or labour of it) has still in himself 
the great foundation of property;... (Locke,1978, p.158). 
 
 
Locke argues that humanity can in itself, both of person and of physical body, have 
ownership of himself and therefore claim oneself as a form of property by virtue of acquiring 
ownership of things unowned in nature. However in acquiring such ownership, Locke, like 
Kant, prohibits acts of slavery, prostitution and suicide, but based on religious grounds that 
Man is not the complete owner of himself but rather the property of God, who created Man. 
While Locke’s theory does not explicitly mention genetic material, it can be assumed that in 
his argument of private ownership of the human body, that biological materials that yield 
genetic information, such as blood and tissue, are also considered a state of private ownership 
based on the premise that they belong to the body that is producing work.  
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2.4 Kantianism 
Immanuel Kant, in his teaching of morality emphasised that a moral act is one that is done 
autonomously. He states that, “Autonomy of the will is the sole principle of all moral laws 
and of duties in keeping with them”38(p150) . Kant’s view of autonomy is one that aims to hold 
all living persons to their duty to respect the intrinsic value, worth and dignity of other human 
beings. 
Kant emphasises the point of unconditional worth and ability to be in control of one’s own 
behaviour because they are rational human beings in saying,  
“The capacity to set an end-any end whatsoever- is what characterises humanity (as distinguished 
from animality). Hence there is also bound up with the end of humanity in our own person the 
rational will, and so the duty, to make ourselves worthy of humanity by culture in general by 
procuring or promoting the capacity to realise all sorts of possible ends, so far as to be found in a 
human being himself”38(p154) 
Based on these qualities he argues that all persons are deserving of dignity and respect on the 
basis of freedom and equality. He states. “The lawgiving itself, which determines all worth 
must for that very reason have a dignity, that is an unconditional, incomparable worth; and 
the word respect alone provides a becoming expression for the estimate of it that a rational 
being must give. Autonomy is therefore the grounding of the dignity of human nature and of 
every rational nature.”38(p436) Law giving in the context of this statement made by Kant 
alludes to the requirement to have one’s maxim universalised. Therefore, if the law provides 
that one’s maxim should be universalised then participating in lawgiving gives one the 
unconditional worth of a morally good will.  
Kant’s moral code sets a precedence that depicts the worth of humanity as immeasurable and 
infinite, thus Kant argues that because of such worth appropriation or ownership of a person 
or their actions is unobtainable. If ownership of one’s body by another could be allowed, it 
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would then reduce the worth/value of that person or their actions to a mere quantifiable state 
or property that can either be sold, exploited or destroyed if one wished to do so.
38
 
2.4.1 The Categorical Imperative 
 
“Humanity is free and exercises that freedom through moral action”38 
Our duties are derived from a categorical rule, which Kant calls the Categorical imperative 
and so defines as, “Act only according to the maxim by which you can at the same time will 
that it should become universal law.”(p18) The maxim employed must therefore be absolute 
such that that the duty which is imposed on one person is imposed to all universally. In this 
case the universal norms must exist without contradiction to all. For example, the act of lying 
is not universalisable because the act of lying requires that the person being told the lie is 
under the impression that you are telling them the truth. The second categorical imperative 
states that one should, “Act in such as a way that you treat humanity, whether in your own 
person or in the person of any other, always at the same time as an end and never merely as a 
means to an end.”38(p150) 
These 2 maxims can be used in formulating a guideline for making moral decisions. Like a 
chemical formula, a moral code also requires certain steps to be followed in an attempt to 
determine if a maxim is universally valid or not. Johnson identifies four steps in this decision 
making procedure
50
. Firstly, formulate a maxim that enshrines your reason for acting as you 
propose. Secondly, recast that maxim as a universal law of nature governing all rational 
agents, and so as holding that all must, by natural law, act as you yourself propose to act in 
these circumstances. Third, consider if your maxim is even conceivable in a world governed 
by this law of nature, if yes, then fourth, ask yourself whether you would or could rationally 
will to act on your maxim in such a world. If after assessing these four tenants in view of 
your maxim, and make the decision that your maxim is indeed valid, then the action becomes 
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morally permissible. The actions then of a morally permissible act, supported by the four 
tenants that make it so then alludes to the moral standing that all human beings capable of 
rational thought should always be considered the end product of a moral act and never as an 
instrument or means to that end. 
Thus Kant argues that the moral duty to humanity should be without ulterior motivation and 
without reward that would not be of universal standing. These “self-regarding” duties include 
refraining from committing suicide, engaging in voluntary servitude, or failing to develop 
one’s own talents.38 In staying in focus with the topic of discussion of this research, it would 
be assumed that Kant would support the maxim that rational beings ought not to sell one’s 
organs or any other biological material or have it taken without compensation as those body 
parts do not belong to that individual as a form of property in the same way that their house 
or furniture does. These acts do portray a form of self-regarding duties and therefore forbids 
the right to sell it. 
However whilst Kant’s philosophy is highly applicable to self regarding duties, should Kant 
be alive today it would be interesting to see how he might have reconstructed this theories to 
the current day and age requirements. This is something that Taylor
39
 tries to do as discussed 
below. 
2.4.2 Commodity and Self-ownership 
 
Kant’s understanding of what self-ownership entails is characterised by the principle of self-
ownership not being able to be universally accepted. Taylor
39
 alludes to Kant’s categorical 
imperatives with regards to self-ownership, stating, “In Metaphysics of Morals, Kant asserts 
that someone can be his own master but cannot be the owner of himself, still less can he 
dispose of others as he pleases – since he is accountable to humanity in his own person.”(p71)  
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However self-ownership is a concept that can be interpreted in more than one way. Some 
might find Kant’s view on accountability to humanity difficult to merge with autonomy in the 
foreground of self-ownership. If you consider that your actions must reflect that of humanity 
then at which point does one attain a sense of self, individuality? By constantly aiming to do 
what humanity expects of you, appears to induce coercion or a form of ethical imperialism or 
a paternalistic maxim.
39 
Taylor applies Kant’s categorical imperative to the issue of a 
paternalistic maxim in determining its validity as a universal law. The argument made by 
Taylor notes that for self-ownership to be valid for a rational being, that being must execute 
his duties as an autonomous agent capable of self-control; otherwise he will risk substituting 
his own wills for those whom he aids.
39
 This can be thought of as a similar reaction that Kant 
would have to the notion of voluntary servitude.  Aristotle also makes reference to the 
application of self-control in relation to self-ownership in his example of the slave where he 
refocuses the concept of self-ownership on a ‘natural slave’ who as interpreted from 
Aristotle’s work is someone who enslaves oneself because he is unable to control his own 
desires and because he cannot control these desires he is regarded as ‘unfree because his 
reason could not prescribe a rule to his bodily appetites”.34  
 Robert Nozick
40
 extends Kant’s argument of human worth and dignity with that of Locke’s 
argument that humankind should be allowed to have private property, using the second 
categorical imperative (that people are ends in themselves) as a mode of rationale for moral 
justification of self-ownership. Nozick submits that Kant’s categorical imperative is just but 
advocates that individual liberties, that is, being able to make decisions about oneself should 
be made without external influence, and thus holds to the ideal that one may treat oneself as 
an object of property. Nozick however falls short in trying to provide a clear understanding as 
to why, apart from acknowledging Locke’s theory towards ownership. Nozick does however 
provide an entitlement theory for acquiring property. He defines the theory as follows:
40
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 A person who acquires a holding in accordance with the principle of justice in 
acquisition is entitled to that holding 
 A person who acquires a holding in accordance with the principle of justice in 
transfer, from someone else entitled to that holding, is entitled to that holding 
 No one is entitled to a holding except by applications of the first two definitions 
Nozick therefore advocates that things held in private ownership/property can be transferred 
or bequeathed from one to the next provided that such a transfer is done in a way that 
portrays the act of legitimacy and that the state should not interfere if the transfer or 
acquisition of that property is just.
40
  
Halewood
41
 then takes on the concept of self-ownership even further. He argues that there is 
a link between self-ownership, commodification (property) and personal liberty rights. He 
posits that “the universal commodification of the person produced by biotechnology can 
actually democratise and broaden the applicability of rights of self-ownership.”41(p133) In his 
argument, Halewood plays on the duality in which he proposes self-ownership can be used to 
describe not only “autonomy or a right to maintain the sacred wholeness of one’s person or 
body, but also the opposite, that is, the capacity of a person as a transactor to deal in his own 
body or person as a commodity.”41(p134) 
He defines his argument by pointing out that commodification of the body (and its parts) are 
without a direct link to identification and does not allow for discriminatory ethos, which he 
uses as a paradox in extending self-ownership to commodification. His defence also includes 
a necessary need for checks and balances to be in place as a means to prevent ‘new forms of 
oppression’.41 One method of doing this, advocated by Halewood is through ‘partial-market 
inalienability’ of human genetic material and tissue. He mentions that self-ownership extends 
further than the self [body] as property but also includes all parts that make up that self and 
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that these elements need always be thought of as individual items or property and are thus not 
always able to transfer to new ownership.
41
 
Furthermore, Halewood points out that in the age of such advanced biotechnology, the human 
body, genetic material and information have become part of a ‘post-modern property’ and 
‘hyper-reality’ such that the body no longer only exists as a physical object consisting of 
matter but has now taken on the role as a ‘body of information.’41 
This, ‘body of information’, has in the post genomic age, led to an increase in intellectual 
property rights, creating more control over segments of genetic and other biological material. 
This increased grasping at intellectual property rights, specifically in the form of patents has 
led to what has been described as a ‘body fragmented by technology’ and so deeply analysed 
that these fragments have become “discrete exploitable reservoirs of molecular and 
biochemical products.”41(p140) Hence any application of the concept of personhood to these 
products is completely removed. This very conception where no person truly exists can be 
assumed to be the driving force behind intellectual property rights such as that of patents on 
genes and gene fragments becoming ever more prominent. 
Halewood uses the increased commodification though biotechnology to enforce Lockean 
theory and self-ownership based on the maxims that the biotechnology industry applies both 
universally and without discrimination.  He therefore provides for Nozick an argument that 
supports his notion that one should be able to treat oneself as an object. 
The philosophical discussions made in this section reflect a strongly western influence which 
portrays a strong emphasis on the autonomous being and is therefore regarded as being too 
individualistic. An approach that caters to philosophical challenges with regard to population 
groups and communities needs to be considered. This approach is known as global bioethics. 
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2.5 Global Bioethics: The communitarian approach 
 
Global bioethics was introduced in the 1970’s as a means to bring to the scientific 
community, beyond that of pure medicine, a more global moral insight
42
. The extension of 
medical ethics to bioethics is said to be mediated by the view that medical ethics was too 
narrowly focused (doctor-patient) to deal with the now ethical issues of humankind, some of 
which include genetic research, genomics and large population group studies. 
Global bioethics is used as a means of discourse due to widespread technology transfer 
internationally as well as the increase in the recruitment of research subjects for biological 
material from developing countries. 
Potter argued that there are three stages involved in the development of ethics
43
. These three 
stages he describes through Aldo Leopold’s environmentalist theory, ‘The Land Ethic’33. The 
first stage investigates the relationship between individuals, the second stage looks into the 
relationship between the individual and society and the third stages attempts to show a 
reciprocal relationship between humanity and his environment.
43
 Only the first two stages 
will be considered in the research paper in efforts to stay in context within the research topic. 
Potter envisions global bioethics as a platform to address the fundamentals of the word 
‘global’, such that the understanding of the system of ethics can be universal and 
comprehensive, by illustrating that bioethics or ethics overall for that matter is shared by all 
throughout the world. Not only does it transcend national boundaries but it also affects each 
and every person universally.
42,43
 He therefore translates universal ethical behaviour into the 
theory that there is interdependence among people all around the world.  
The need for global bioethics becomes imperative so as to prevent interdependence leading to 
exploitation or bullying with specific mention of those of the developing world being of 
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greatest risk of such possibilities
28
. Potter understood that the opportunity to take advantage 
of those ‘smaller’ than you is an ever-present risk and thus promotes the unification of 
everyone in the world as a global community geared towards a practise in morality that 
allows for both access and benefits of biomedical progress to be shared equally, removing the 
risk of lower-income countries being excluded
42
. 
The concept of global bioethics highlights the significance of the community.  Henk ten Have 
points out two reasons why community has such relevance in global bioethics
23
. He states 
firstly, “that global bioethics necessarily reaches beyond the western individualistic 
perspective of traditional ethical systems… ethical systems of different cultures need to be 
examined and moral values analysed and applied in specific context”(p318). The second reason 
he proposes is that, “awareness that individuals are embedded in relationships, communities 
and the wider world is moving contemporary bioethics to a broader social setting.”(p318)  
These points of reasoning relate to Potter’s first 2 stages mentioned above for the 
development of ethics
34
. 
Overall the application of global bioethics necessitates an adaptation of conventional 
bioethical concepts, such that, issues of autonomy and informed consent may be interpreted 
differently between western and non-western cultures. 
The concept of global bioethics can be associated with issues surrounding genomic 
sovereignty, as well as the common heritage concept. The ethical concept advocates for 
distributive justice or a collective duty to provide some level of benefit to a community 
(population group)
44
, either through the action or contribution of the community as a whole 
or by an individual member representing that community.  
In the African context, the theories of communitarianism in combination with African 
philosophy such as that of Ubuntu can be used in promoting proper ethical conduct in 
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genomic research initiatives.
45
 It is common-place in African tradition that decisions made, 
particularly when these affect said populations directly, are made by public discussion and 
deliberation. Unlike western majoritarian political structures, most African customs promote 
discussion between communities, leaders and elders in efforts to find a compromise rather 
than choose one option over another
45
. This approach may prove more beneficial in opening 
up a more participatory discourse between researchers and respective communities, in 
principle at least. 
The example above provides for discourse regarding global bioethics principles to be dealt 
with from a community and cultural based approach. Therefore it may be of the opinion that 
western bioethical ideals appear to autonomous and culturally insensitive to non-western 
populations. However the perception may appear too harsh and critical of western centric 
approaches due to a lack of understanding or interpretation of a western approach and vice 
versa.  
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3. Discussion: Ownership of Genetic Material  
 
Using western philosophy, one can easily associate guidelines to genomic research with 
individualism. It denotes a person’s willingness to participate in a research study and allow 
the use of his/her biological material and thus decide independently how to regulate its use, 
benefits and access. But genomic sovereignty and the common heritage concept are based on 
genomic research of populations (greater than one person). Thus such bioethical concepts 
need to be revisited and re-interpreted in order to compensate for a ‘greater than one’ 
scenario. 
3.1 Group ownership and Genomic Sovereignty 
 
As a general form of understanding a group can be broadly defined as a number of people 
that share a common characteristic or interest
46
. In genetic research, the context in which such 
definition is understood becomes a little more specific. Two types of genetics groups are 
defined here
47. The term “Demes” is used to describe or identify a set of people that share 
relevant genetic information. The other group is identified as the “ethnoi”, which are 
described as being self-identified or other-identified social groups based on categories such as 
culture, language, race, territorial occupation, etc
46,47
. 
For those identified as ‘demic’, it is difficult to assert any claim as a group over their genetic 
information, such that these individuals are unidentifiable as a set group until research and 
analysis has been completed. Therefore while autonomy and respect for persons can be 
maintained on an individual level, as a group their moral standings appear to not exist, thus 
making claims over genomic sovereignty obsolete. Thus classification as demic in genetic 
research provides little or no protection over the genetic information discovered
46
. 
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To help understand this concept, consider the example of blood groupings. Globally human 
beings are either one of 4 blood types (A, B, O or AB) with a corresponding rhesus factor 
(positive or negative). Having a specific blood group is not unique to oneself, even if one is 
classified as a having a rare blood type, that person will still fall within the lowest percentile 
for an entire population. Thus whilst such a blood type may be difficult to find, it is in no way 
unique to a specific person but rather he/she would belong to a group that is classified as 
having such a blood type.  
The point illustrated here is that one cannot claim control or sovereignty for that 
characteristic simply because the members of such a group are too large a number and 
dispersed globally, thus further removing the issue of national sovereignty. This seems to be 
the case for those of the demic grouping. However such research subjects are rarely a focus 
of a genetic study. It is rather those of the ethnoi grouping who are the most common subjects 
of genetic research.  
The ethnoi
46
 as previously mentioned are self-identified or other-identified social groups, 
which although classification for this group may not be of genetic connotation, these varying 
factors are still considered critical components that drive genetic research within such groups. 
Thus these specific groups are able to impose or leverage their genetic data for claims over 
genetic control of both sample and data, i.e. sovereignty
47
. Research involving ethnoi groups 
are usually selected based on a “unique” externally unknown genetic characteristic that 
allows them for example, to metabolise faster, show immunity to a specific disease or 
conversely make them more susceptible. Such research is generally conducted in a localised 
environment thus prompting the need for sovereign control over such data. Since researchers 
have a vested interest in a specific set of people, it stands to reason that there is something of 
specific interest within them that researchers wish to explore further. 
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As Juenst portrays it
48
 , “it is the history, migration and relative disease burdens of 
humanity’s many socially defined groups, not our anonymous demes that derives most 
descriptions and defences of population- genomics research”(p675). Thus the assumption made 
here is also central to genomic sovereignty. These are the assumptions that the genetic 
information within a set population is unique and of commercial and symbolic value. 
However it is known that there is <1% genetic variation between individuals, thus implying 
that most of the genomic sequences found from one individual to the next are almost the 
same
1
. Hence it stands to reason that what researchers may perceive as a unique variant 
within a specific population group is indeed flawed. One can accept the fact that such 
variation can occur in a higher frequency within a population set due to certain factors that 
they hypothesise but in any case their findings for genomic uniqueness falters as individuals 
with the same variant could always be found in another population.  
In the age of Genome Wide Association Studies (GWAS), microarrays and next generation 
sequencing, genetic markers that confer risk profiling and predictability testing use more than 
one variant as a mean of determining one’s at risk profile, thus in order to gain greater insight 
into one’s disease risk, haplogroups/types are generated that can be used as predictive 
markers. It can also be assumed that whatever the research is focused on, there will always be 
a patient with such ailment outside of the sample size for such study. 
Thus if the quest for genomic sovereignty is to protect genetic information of a unique 
population group, then scientific evidence tends to lend itself to the converse, weakening the 
argument for genomic sovereignty
47
.  
Therefore, one needs to consider what other motivation there might be for seeking genomic 
sovereignty for a people, nation or state. If the argument towards unique genotypes cannot 
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substantiate for a strong enough argument to claim genetic information as a sovereign 
resource then other mitigating factors need to be brought in to support such argument.    
One motivation for claiming genomic sovereignty and perhaps the greatest contributing 
factor are the tangible profits that could be made from such research. If those concerned 
(people, nation or state) do not enforce some level of remuneration for contributing to the 
science that has led to the breakthrough down the line then the doors for exploitation are free 
to open and take from the people as they see fit
47
. This also ties in with the notions of access 
and benefit sharing.  
Another motivation for promoting genomic sovereignty is that of increasing the 
knowledgebase of the country involved
9,47
. For developing countries such as South Africa, 
research initiatives that involve collaboration with more developed countries such as the 
United States or the United Kingdom allow local scientists the opportunity to be recognised 
in a volatile field where it’s either publish or perish. Furthermore it allows those in 
developing countries the opportunity to sharpen their skills, by working with international 
collaborators and technologies that are unavailable to the developing world. If these ideas can 
all be used together it may be possible to create a strong motivation that would allow a nation 
or state to regulate genomic research in their country. 
3.2 Group ownership and the Common heritage concept 
 
The common heritage concept is used as an argument against the ideals of genomic 
sovereignty, such that the common heritage concept takes on a more utilitarian argument 
(greatest good for the greatest number).
46
 The argument made for common heritage is that the 
group in question here isn’t that of an indigenous group or of people of certain terrestrial land 
but rather all of humanity.  
~ 40 ~ 
 
From an ethical point of view the argument stems from the concepts of global bioethics, in 
that we are all part of a global community, if people within this group are found to have 
certain genetic characteristics that would be beneficial to the understanding of a disease or aid 
in developing a therapeutic intervention then these findings should be shared with the rest of 
that group, that is, the global community
23
. If we consider Kant’s theory on moral duty then, 
overlooking the point that Kant does not consider commodification of the body as morally 
just, the act of sharing knowledge and information is a maxim that can easily be associated to 
the categorical imperative thus making it universal in nature
50
.  
The role of common heritage has a duality in its understanding and comprehension. While the 
literal interpretation invokes property, ownership to all of humanity, the level of ownership is 
dependent on the doctrine that is used to define it. There are two doctrines that can be used 
that relate to regulating the commons, these are res communis and res nullius. 
26,27,29
 
Res communis as previously defined above states that all human beings are part of the 
collective known as the human race and that no person is to be excluded at all irrespective of 
colour, creed or social background
26
. It allows for appropriation of a resource for the use of 
all of humanity, such that no individual may own it exclusively and that such a resource 
should be shared equally. 
Res nullius employs the same tenets but juxtaposed with Res communis delivers a different 
outcome with regard to ownership, such that the global commons is said to belong to no one 
(which indirectly implies ownership by all) but allows for alienation to an individual if the 
mode and reasoning for such acquisition is both ethically and legally valid.
23,26
 
Based on the description of these two doctrines, it is most likely that the UNESCO 
Declaration, stating that the human genome is to be considered ‘heritage to humanity’ was 
employing the doctrine of res communis. However the current landscape towards ownership 
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paints a rather different picture more reflective of res nullius. Evidence of this can be found 
throughout the world, more so in the developed countries, by appropriation of patents for 
genes found in the human genome
32
. It is likely that the res nullius doctrine is employed by 
intellectual property agents through claims that those who succeed in isolating a gene should 
be allowed to claim ownership over it based on the understanding that since no one owned it 
before despite it being present in everyone, then now that it has been discovered, extracted 
and isolated by an individual (group of individuals, biotech and pharmaceutical companies) it 
then can be rightly claimed by that individual as his own property
23,26,29
. Additionally, there is 
far greater economic growth and returns on investment based on the exclusivity of a resource 
such as a gene patent rather than having to share profits on a global scale, all of which cannot 
be possible in the absence of property rights. 
It is of noteworthy importance to state that the opinions with regard to patenting in this 
section are generalised based on the US approach before the 2013 Myraid Genetics
76
 law suit 
was concluded and that the omission of a European approach within this section is due to size 
constraints of this report. 
UNESCO’s Declaration of humankind’s common heritage in consideration of the doctrines 
mentioned above is more likely to be interpreted metaphorically, where all are urged to unite 
and act as one, but is more likely to be of greater impact in issues such as global warming 
rather than that of genetics. Despite this current situation with regard to ownership, property 
rights and patenting, the idea of common heritage still remains a force that some still continue 
to use as a means to influence ethical and political debates regarding commercialisation of the 
human genome and its genes. 
The common heritage principles mentioned in the section above highlighted five points that 
can be used to build a definition for common heritage. The first four are fairly simple to 
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interpret with the fifth principle requiring further elaboration. To reiterate, the fifth principle 
states that the commons should be preserved for future generations, so as to avoid a ‘tragedy 
of the commons scenario’. 
The ‘tragedy of the commons’, made popular by Hardin68 highlights the risks and 
consequences of over-exploitation of a common resource through unrestricted control and 
access, concluding that ‘freedom is the recognition of necessity’, and that the abuse of that 
freedom is the primary cause for a tragedy of a commons. The question remains: could there 
ever be a tragedy of the commons scenario with regard to genes? 
Logically it seems impossible, for as long as human beings exist, access to the human 
genome from a biological point of view will always be available. Furthermore, in a 
technology driven age, gene sequences are capable of being immortalised through digital 
storage of their sequence data. I therefore argue that in trying to define the human genome 
and its genes thereof as common heritage that a tragedy of the commons scenario lacks 
sufficient evidence to support the common heritage principle. Instead an ‘anticommons 
scenario’67 is more likely to occur, which is discussed further in the legal component of this 
research report. 
While it is understood that the common heritage concept is meant to protect resources 
deemed common heritage and ensure global benefits to all, such as the efforts made toward 
that of the human genome and its genes, it falls under criticism in its lack of protection of 
group ownership on a more local scale. 
For example, Sandel
49
 argues the moral claims to a “cosmopolitan citizenship”. In his paper 
he advocates for the role of the community to be scaled down and identified as individual 
groups. He emphasises that the moral relevance and importance of community are those 
which are located throughout the world and that the global community fails to protect 
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everyone equally. ten Have
23
 tries to offer a counter argument in which he bases his premise 
on the linkage between global and local communities. His defence is that “the global sphere 
is not a domain in itself, separate from other domains. It includes them all, and at the same 
time, manifests itself in each. That means that there is no opposition between the global and 
the local. The global is produced in the local; what we understand as global is constituted 
within the local. The global escapes the communities of its creations and at the same time 
manifests in them”.   
Common heritage employs the ethical teachings of utilitarianism by making the assumption 
that the interest of the many outweigh the interests of the few.
46
 This however is not the case, 
as not everyone can or will have genetic testing nor can any person be forced to do so or join 
a medical research study even if the potential benefit would be for the greater number of 
people. Thus while the common heritage concept in principle employs a utilitarian ethic, it 
can be limited in its reach. 
Although one might argue for a supreme emergency where individual or group rights are 
sacrificed for a perceived greater good, and where testing and research is coerced and 
mandatory. However owing to the possible rarity of such extreme circumstances, it may 
appear that in the current setting of genomic research and testing that the former argument 
holds greater poise.   
3.3 The common resource argument 
 
There are those who rather than view the human genome as common heritage or even a token 
of national sovereignty, motivate for it to be thought of more as a common resource. 
Proponents advocated for the common resource argument based on the following tenets; 
firstly, it removes the common property right in the genome, secondly, global ownership 
interest is also reduced to only those who have a specific interest in the genome and/or its 
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segments. It thus allows for commercialisation of that resource by individuals, companies or 
countries.
27
 By allowing the human genome to be considered a common resource it thus 
allows for both moral duties as well as legal platforms to be imposed in a more specific and 
focused manner as there would now be a smaller focus group to concentrate on rather than 
trying to control such concerns on a global scale. 
The concept of ownership in view of the common resource argument also requires a 
paradigm shift where ownership of the human genome isn’t seen as the most suitable means 
in protecting itself.
21
 Where exclusivity is found there is room left for exploitation and 
selfishness in withholding the resource to one’s self. Rather the ideals of stewardship are 
promoted as an alternative.
27,41,42
 Furthermore, the five principles used to define a common 
heritage appear to fit in better with the common resource model as stewardship requires that 
those who undertake such responsibility do so with the intention to take care of such a 
resource and treat it with significant worth such that, in tune with the fifth principle, it be 
preserved for future generations. 
3.3.1 Duties of stewardship 
 
A steward in absolute simple terms is someone who is given the duty or put in charge of 
taking care or overseeing something for someone else, in other words, being made the 
trustee.
27
 From an environmental ethic point of view, those afforded the role of the steward 
are to, as part of their duties, not only take care of the item but also prevent harm from 
coming to it, in other words prevent a tragedy of the commons scenario
68
. From a genetics 
point of view this would entail protecting the human genome and by association its genes 
from act of maleficence, such as the loss of genetic diversity, creation of harmful genetic 
mutations or negative eugenic practices. 
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Stewardship can be seen as a means of merging the ideals of genomic sovereignty, common 
heritage and the common resource argument, specifically with regard to group ownership. As 
previously mentioned the common resource model allows for appropriation of a resource by 
an individual, company or country
5
. If one excludes the term company from this definition 
then the common resource argument starts to show a similarity to the definition of genomic 
sovereignty described earlier. Within genomic sovereignty heritage is spoken for as well in its 
definition by the terms ‘nation’ and ‘people’. A nation or people of a country carry with them 
inherent and inherited indigenous knowledge, perceived as a common resource to those in 
that area
83
. Thus those who carry with them this indigenous knowledge have a duty to pass on 
the information from one person to the next both inter and intra generationally. Hence the 
information is preserved, transferred and shared from one to the next generation. Each person 
is therefore incidentally an honorary steward whether aware of it or not.  
The act of stewardship provides for those of specific groups to allow the use of their genetic 
material without handing over exclusive rights to such materials. In this way, a research 
initiative that aims to use a specific population group is afforded the opportunity to decide 
whether they are willing to submit to the researchers their biological samples and state the 
terms and conditions under which their samples are used so as to address the cultural needs 
and sensitivities of their community
23,27
. Furthermore a stewardship model allows for such 
communities to set more specific terms and conditions to access and benefit sharing to their 
communities. From an African perspective, the foundations of stewardship reflect similar 
findings to that of the way of Ubuntu
45
.  
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3.4 Ethical conclusion: Ownership and Property 
 
Kant’s philosophy in essence would agree that freedom from interference is necessary as it 
forms an implicit and fundamental component of autonomy but still affirms the duty to treat 
one’s self with the same respect and dignity that is to be afforded to others.38  
For example, helping a fellow Man in some ways does have moral worth. Thus if we consider 
Kant’s Maxim38,50, that a person cannot be used as a means to an end, but as an end in itself, 
then, under current bio-prospecting understandings,  using one’s populations resources to 
benefit another with no ‘reward’ to the contributing donors is ethically flawed. However, if 
such samples were collected through the proper channels such as informed consent from the 
population, with the notion and intent that they too would benefit, such that intrinsic value, 
dignity and worth for human life is maintained by providing adequate mandates such as that 
of informed consent and benefit sharing. 
Although Kant’s stance on self-ownership is a negative one, a defence of self-ownership can 
be made on the ideal of a duty of physical non-interference, that is, the duty to respect the 
bodily integrity of other persons.
39
 This in turn produces a limitation right for that person, 
that is, the right not to intrude or interfere or trespass on one’s own person. This limitation 
right consequently provides for an autonomous person to be able to not only forbid actions 
against themselves but also allow temporary level of use. 
For example if we consider the right to use common property such as a recreational park, 
where a person lays down a picnic blanket
34
 on a certain area of the park, that person 
executes their right to use that portion of the park, thereby limiting that area’s use by others. 
It is a temporary claim that can be removed. Assuming that the picnic blanket only covers a 
portion of the area not obstructing anyone else from enjoying the park, this temporary claim 
can be permitted. This example relates to the common heritage concept principle whereby use 
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of a common resource, such as human genetic material, is permitted provided it does not 
impede on its use by others.  
Another example is the right of transfer
39
 which can be applied as an indirect derivative of 
the right of exclusion. If we consider the scenario of people working out at the gym, when I 
am using one item of equipment, I am exercising my right to exclusion. I am using it now and 
therefore no one else can use it. However once I am done using the equipment it should be 
passed over to the next person requesting its use, that is, transfer the item from me to another 
party.  
This example represents a duality of ownership in property. The first is one of common 
property. Since the gym is communal is can be shared by all who visit it. It is important to 
note that in a gym there is usually more than one machine or equipment of the same type thus 
allowing more than one person to use the same machine all at once. Again this type of 
environment does display a form of common property, such that we have many people in a 
common area utilizing the same work space and sharing it among their fellow gym partners.  
Hence all the equipment in that gym is for common use. The equipment is owned by no one 
who works out there therefore temporary ownership can be recast again upon opening the 
gym again the following day. This form of ownership can be associated with the common 
heritage concept doctrine of Res communis,
29
 which has been previously described as, all 
human beings are members of the human race regardless of whether they live in the 
developed or developing world, “things” cannot be appropriated such that everyone should 
have access to its use. The use of a resource is allowed only if it is not be held in monopoly or 
within exclusivity to one person or company insofar as one’s use for this resource should not 
impede its use for the next
51
. 
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Using this example, if we widen the lens a little, ownership of property takes a turn from 
common to sovereign. We understand that sharing the equipment in a gym is to be considered 
communal, but a gym is a business in which, overall, the equipment within that building sole 
ownership is awarded. Hence those who choose to use these types of gym equipment do so 
with the consent of the gyms owner. Therefore the gym acts as a sovereign resource for 
which all rights of use of its equipment are reserved with the gym owner.  
A gym like all businesses also needs to gain some form of income to sustain and maintain it 
so that it continues to provide a service to those who want to use it. This is done by charging 
patrons a membership fee which in turn grants the patron access to and use of the gym and its 
equipment. In the same way, a country (gym owner) that regards its resources such as genetic 
material (equipment) as a sovereign resource has the option and the freedom to decide on 
what grounds their genetic material can be used for and what the benefit to that country 
supplying such material is likely to gain. 
It should be noted that the scenario depicted above is portrays the idea that national 
sovereignty is the accepted norm. It however does not take into account an individual’s right 
to own his/her own genetic material and use it as he/she wishes. 
This now presents a dilemma in which a property type, such as a gym or human genetic 
material, can be represented as both common and sovereign. The question then to be 
answered is how we justifiably harmonise these to concepts that tend to present varying 
ideals with regard to ownership? 
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4. International Bioethical guidelines associated 
with genomic research 
 
Guidelines with regard to ownership of biological samples and genetic data involve looking 
into how research is conducted in developing countries, such as South Africa. 
Many of the bioethical guidelines, such as the Canadian Institute of Health Research 
guidelines
52, UNESCO’s Universal Declaration on Bioethics and Human Rights53 and the 
Organisation for Economic Co-operation and Development (OECD)
54
, provide for ethical 
considerations when conducting genomic research. Much of what is stated in these 
guidelines, while not legally binding, are still capable of guiding legislature into protective 
laws, thus they can be considered to hold some degree of quasi-legal standing. 
The notion of stewardship and justice as advocated for by Leopold
33
 in the form of access and 
benefit sharing is made evident in many of the research guidelines surrounding genetics. For 
example, the CIHR issued guidelines for health research involving aboriginal people in 
2007
52
 which infers the notion of co-ownership and stewardship in their research, such that 
samples used in research are to be considered to be ‘on loan’ to the researcher unless 
otherwise agreed upon. 
Justice, access and benefit sharing are provided for in the OECD guidelines
54
. Whilst these 
guidelines are not specific to genomic ownership the principles therein can be applied to the 
issue at hand.  
For example the OECD guidelines
54
 with regard to Human Biobanks and Genetic Research 
Databases (HBGRD) present culturally sensitive recommendations with respect to 
custodianship/stewardship as well as benefit sharing. Furthermore, under the issue of access 
(fairness and transparency) one of their “best Principles” points out requirements for 
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researchers to set out policies that allow participants to view or get information regarding 
themselves in research involving their biological contribution. They also make the 
recommendation that participants consent to the type of research that their sample and data 
can be used for. 
In terms of benefits, these same guidelines suggest that before any study can commence, 
policies and contracts should be drawn up and agreed upon by both researcher and research 
participant,
54
 especially in the case of population level studies, where there may be vulnerable 
populations or unique concerns. These guidelines also include statements made with regard to 
commercialisation or resources or lucrative gain in commercial products obtained from 
research activities as stated in section 9D of the principles of custodianship, benefit sharing 
and intellectual property. This section states that “the operators of the HBGRD should have 
clearly articulated policy that is communicated to the participants relating to the 
commercialisation of its own resources, research results derived from those resources, and/or 
commercial products, if any that may arise from research using its resources”.54 
Whilst many of the guidelines with reference to genetic material are widely available 
internationally. The degree to which they are enforced differs broadly around the world. 
Furthermore, even though existing guidelines, such as, UNESCOs Declaration of the Human 
Genome and Human Rights or the CIHR or OECD, they aren’t legally binding documents but 
do play an important role in affecting legislature and policy making decisions. 
4.1 Community benefit 
 
Once a researcher and a community have reached an agreement with regard to the research 
being undertaken a relationship between the two parties is then formed. This relationship is to 
be maintained, especially in developing countries, even if an individual is used from that 
community - as he is positioned to act as a representative of that community. The relationship 
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formed should reflect a supportive and caring nature to the community with a sense of 
solidarity to the community based on the benefits stipulated within the community.
23,54
 
Benefit sharing stipulates not only that an individual benefit from research participation but 
also the community he belongs to. The ‘rewards’ in the form of some benefit to a community 
first emerged in the 1980’s as a principle to try and alleviate the amount of bioprospecting 
and biopiracy that was happening during that time. In 1992 the UN Convention on 
Biodiversity noted that the principle of benefit sharing should be used as a means to 
‘appropriate access to and use of genetic resources’.55 The required access to communities 
implies that both the community itself as well as the indigenous knowledge that they carry is 
worthy of producing benefits. The principle therefore states, “that in return for access to 
genetic resources and the use of the traditional knowledge associated with these resources, 
benefit sharing agreements should be negotiated with the local community”.23 
Traditional knowledge is regarded as a property type of a community
9,69,71
, such that all who 
belong to such a community, in whatever way that they are defined, own that knowledge. On 
a local scale, the shared knowledge between community members is regarded as common 
heritage
23
. Thus discussions and agreements with regard to benefit sharing should be all 
encompassing of the local communities needs and, in doing so, reach an agreement which 
allows the researchers to obtain the required genetic resources and the providers of such 
material within a community to be adequately compensated for. It is imperative that such an 
agreement does not become misconstrued with any form of sale or transaction that makes one 
or the other out to resemble that of a buyer and seller relationship.  
Conflating the human body with economic market value, as Sandel
49
 explains, is said to infer 
a form of corruption to the inherent moral value of a human being for “certain moral and 
civic goods are diminished or corrupted if bought or sold for money”. Sandel  argues that to 
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assign monetary value to a human body, makes it’s a commodity capable of being, bought, 
sold, or destroyed as one sees fit and thus creates a shift of worth of the human body from 
intrinsic to instrumental. Sandel’s argument therefore on the basis of ethical principles echoes 
the moral standings and principles found in Kantianism. 
ten Have, in his argument towards benefit sharing raises the concern of how a community 
worthy of receiving these benefits are defined
23
. He advocated for an approach that 
emphasises ‘social ties, shared interests, common perspectives and joint actin besides 
geographical location’ above that of shared disease conditions, race and ethnicity. He also 
emphasises the need to clearly define the target community from whom research requires 
participants. It needs to be understood that biological material and genetic resources tie into 
the community that research chooses to focus on and thus the principle of benefit sharing 
requires proper identification of these communities so as to prevent any act of biopiracy or 
non-essential extraction of genetic materials from those not specific to the target community. 
Most notably, identification of a community allows for any benefits that are accrued to be 
distributed equally among those rightly deserving of it.  
In addition the Human Genome Diversity Project’s Ethical Protocol Model for Collecting 
DNA samples of 1997
56
, like the guidelines mentioned above also provide for detailed 
approaches as to how to approach and plan genomic research. In addition to the standard 
procedures of informed consent, privacy and confidentiality, it is recommended that 
researchers, who are to approach various groups, are to make an effort to first find out about 
social, cultural and traditional concerns with regard to sample collection.  
 
 
“In many societies around the world, hair is secretly collected from intended victims to harm them 
through witchcraft. Consequently, people collect their own loose hair, fingernail parings, and other body 
products and bury them to avoid this danger. Researchers who asked such a population for hair might be 
seen as intending to perform witchcraft. Blood is often intended as a sacrifice, sometimes through 
special rituals. Donation of blood in such cultures is a serious matter that would require discussion and 
perhaps a neutralizing ritual.”56(p1437) 
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This would appear greatly helpful so as to avoid disrespecting population’s cultural practices 
as well as that, by gaining insight by researchers into such cultures; they may be able to avoid 
insulting those populations or find alternative ways to collect samples from them that would 
not be of offense or possibly culturally misleading. 
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5. Legal Framework around Genomic Research 
in South Africa 
 
Based on current legislation, biological samples capable of yielding genomic information can 
under certain circumstances be owned and have rights attached to them. This section will 
explore the ownership of human biological materials, DNA and the information derived from 
such research. 
Ownership with regard to biological human material is addressed to some extent within South 
African law, specifically in Chapter 8 of the National Health Act
59
 and its regulations
65
. 
However, those of the legal fraternity struggle in conceptualising ownership of such materials 
without objectifying a person or people thus laying risk as reducing such individuals as a 
state of property
57
. This infers a reduction in human dignity by rendering one-self or parts of 
that same self as a commodity. The complexity of the issue raises much debate both legally 
as well as ethically. 
The human body and its parts are traditionally classified as res extra commercium (things 
outside of commercial value)
64
. With regard to the body as a whole, ownership according to 
South African law bequeaths ownership status to the person to whom the body is still 
attached to, based on the interpretation of one’s constitutional right to bodily integrity58. On 
the other hand, bodily material that has been separated from its owner (assuming the owner is 
aware and informed consent has been given) lies in a rather grey area legally. Current 
understandings are that of the Res nullius doctrine, which if simply interpreted states that 
materials under this doctrine are said to belong to all due the conditions set out within the 
doctrine that suggest that such property belongs to no one but can be acquired through certain 
means
21,25,57
. Therefore for samples of human biological material, once separated from the 
body, the original owner of that material loses his right to it and it becomes eligible to 
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become ‘property’ of the first person to claim ownership and use of it. The practise res 
nullius with regard to separated bodily materials is borrowed from the legal understandings of 
Roman-Dutch law upon which South African law is based.
57 
5.1 The Constitution, National Health Act 61 of 2003 and Relevant 
Regulations 
 
The Constitution of South Africa
58
, section 12(2) states that “everyone has the right to bodily 
and psychological integrity, which includes the right… not to be subjected to medical or 
scientific experiments without informed consent”. This advocates for the control over one’s 
own body and mind
58
, such that that person has the right to their own autonomy prior to 
medical or scientific experimentation. When applied to the issue of ownership it would seem 
that once someone decides to participate in any form of research, in this case, involving 
biological specimens then ownership of such samples should be re-discussed and agreed upon 
by both the researcher and individual/group through the proper informed consent protocol 
channels. Overall however, apart for inferred interpretations of the constitutional laws, 
ownership of human bodily material is blaringly silent. 
Section 16(1)(d) of the Constitution
58, states that “everyone has the right to freedom of 
expression, which includes… academic freedom and freedom of scientific research”(p1249). 
Interpretation of such legislation is open and can be used as a means of exploitative methods 
to undergo research endeavours. However under limitation of rights, section 36,
58
 this law 
can be restricted to certain rules and conditions through the limitation clause stated within the 
Constitution. It is important to ensure that an ethically justified balance is maintained 
between protecting individuals and promoting scientific research. Justification for limiting 
the freedom of researchers in the field of genetics and genomics can be motioned for by local 
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and international ethical guidelines, but it is important that the laws of the country provide a 
foundation from which to regulate these issues accordingly. 
Therefore, on the one hand, whilst the Constitution can be seen to indicate that one’s own 
bodily materials belong to oneself, on the other hand it promotes freedom of scientific 
research, which in the case of genomic research requires human biological materials. 
Research on or experimentation with human subjects and associated biological specimens 
obtained are covered by chapter 8 of the National Health Act No. 61 of 2003 (NHA) and its 
regulations, which deals with the “Control of use of blood, blood products, tissue and 
gametes in humans” 59. 
The National Heath Act defines tissue as ‘… human tissue that includes flesh, bone, a gland, 
an organ, skin, bone marrow or bodily fluid, but excludes blood or a gamete’59. The 
regulations relating to the Use of Biological Material defines biological material as ‘… 
material from a human being, excluding DNA, RNA, blastomeres, polar bodies, cultured 
cells, embryo’s, gamete, progenitor stem cell, small tissue biopsies and growth factors from 
the same’60. Additionally the regulations relating to Tissue Banks define tissue as ‘… a 
functional group of cells. The term is used collectively in regulations to indicate both cells 
and tissue’61. Lastly, the regulations relating to the Import and Export of Human Tissue, 
Blood, Blood Products, Cultured Cells, Stem Cells, Embryos, Foetal Tissue, Zygotes and 
Gametes define a substance as, ‘… tissue, blood, blood product or gamete’62 and the 
regulations regarding the Clinical Forensic Medicine Services define a body specimen as, ‘… 
anybody [sic] sample which can be tested to determine the presence or absence of HIV 
infection’.63 
Judging from the various definitions toward human biological material mentioned above, it is 
quite evident that their lack of cohesion between one another leaves room for ambiguity and 
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thus lays the possibility for exploitation of such materials, especially from genomic research. 
Genomic research  requires some form of genetic material as a means to conduct a research 
study, to obtain it biological material is required as in all of these sources genetic material 
(DNA and/or RNA) and be extracted. From a legal perspective, the contradictions between 
these definitions hinder the ability to provide a legal classification for human tissue, which in 
turn leads to a variation in what type of samples can be obtained for genetic studies. 
Researchers may choose to define their proposed sample type based on a definition that offers 
them the greatest amount of freedom in obtaining the types of sample they require. 
Furthermore, with a lack of cohesion between these definitions, the rationale to limit the 
expressions of academic freedom and freedom of scientific research becomes difficult to 
impose, leaving room for exploitation. Equally so, the contradictions of these definitions 
make it difficult for those who wish to perform genetic research in South Africa, to dutifully 
state the specificity of what sample type is required for their form of genetic research and 
may thus cause problems in interpretation when seeking ethics approval for the study, in turn 
delaying the study. 
5.2 Understanding Ownership: Legal Perspective  
 
The description of ownership stems mainly from common law. Ownership is described on a 
case by case basis in South Africa, and has been defined in various decisions as ‘the most 
complete real right which gives the owner the most complete and absolute entitlement to a 
thing. Even so, it is a right which can be limited by objective law and by the rights of 
others’.64 A ‘thing’ is defined ‘in terms of characteristics, as a corporeal or tangible object 
external to persons and which is, as an independent entity, subject to judicial control by a 
legal subject, to whom it is useful and of value’.64 
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 Genetic material in this sense is reflective of what a ‘thing’ would be. Genetic material meets 
the criteria that are used as definable characteristics of a thing. It is corporeal, as being 
belonging to a physical body and tangible, as being a material that can be made visible, of 
definite substance and can be quantified.
64
 
According to regulation 180(S26) of chapter 8 of the NHA, ownership of human tissue 
obtained via informed consent is considered the exclusive property of the researcher or 
research institute
65
. This is stated as “Any person who acquires the body of a deceased person 
or any tissue, blood or gamete by virtue of any provision of the Act and these regulations, 
shall, subject to any restrictions in terms of the Act or any other law and provided she or he 
uses the body, tissue, blood or gamete for the purposes for which it has been donated, handed 
over or supplied to her or to him, on receipt of that body, tissue, blood or gamete acquire 
exclusive rights in respect thereof”. Such regulation pertaining to biological material capable 
of yielding genetic material within the NHA portrays a sense of exclusive property rights 
from donor to donee, that being a researcher, doctor, or research institute for example
59
.  
 
This transfer of ownership therefore implies that when elements of the human body are 
separated from a person, the material gained loses its identity and is to no longer be 
considered a biological material that no longer has relatedness to the person whom has 
donated it. This may be true for biological material removed from a person as it can be coded 
or anonymous but the genetic information within those materials are capable of identification. 
For example if a population group under genetic investigation if found to hold in their 
genomic sequence a rare variant or SNP that specifically clusters within that group, it then 
acts as an identifiable marker to that population. Depending on the type of genetic association 
predicted to be linked to that SNP a population can become vulnerable to further genetic 
exploitation and cultural intrusion. Thus, while national regulations display ownership of 
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biological and genetic materials as a property that can be transferred from one person to 
another, the intimate nature of genetic material begs the question of, to whom does such 
material truly belong? 
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6. Genomics and Gene Patenting 
 
Prior to the recent international ownership issues relating to genetic material such as that of 
patent laws , the common understanding was that such material was an open source with no 
one having exclusive rights to ownership over any piece of it thus allowing all countries to 
share their genetic resources freely.
66
 An example of open source in genetics is that of the 
Human Genome Project, an endeavour that required the collaboration of a number of 
different institutes sharing their information and data, therefore forcing each of them to 
decide on flexible research standards. 
Safrin
66
 refers to the “legal enclosure of genetic material”, which she attributes to two 
developments: Firstly, the patenting of genetic material by predominantly developed 
countries and, second, a response to the privatisation of genes through the patent system the 
extension of sovereignty over genetic resources by developing countries. This action has then 
led to a reaction by many states of the developing world to begin implementing state 
sovereign rights or a form of national control over genetic resources within their borders. The 
interaction between the patent system and the sovereign-based system is described by Safrin
66
 
as a “corrosive interplay” eventually leading to a system she describes as “hyperownership” 
of genetic material to the anticommons trap. 
The anticommons is a concept introduced by Micheal Heller
67
 as ‘the mirror image of 
common property’. Whilst the Tragedy of the Commons68 is a philosophical idea expressed 
by Hardin that sets fort the consequences of overuse of a natural resource, such that access to 
that resource is overrun, the anticommons proposes the opposite: a tragedy is likely to arise 
“when these individuals or entities employ their rights to veto the use of a given resource and 
in so doing waste the resource by it’s under consumption compared with the social 
optimum”67(p621) 
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Hardin’s Tragedy of the Commons represents over-consumption and exploitation of a 
resource without giving back to the entity from which it was taken. Heller’s anticommons 
approach aims to identify the lack of willingness to allow others access and share in the 
benefits of that resource. From a genomics point of view this represents the effects of 
safari/helicopter research, whereby genomic samples were collected from communities 
without proper consent or fair compensation, that has happened in the past consequently 
leading to many nations seeking sovereign mandates over their genetic materials. In either 
case the action of both these groups incurs both social and economic repercussions.  
Additionally, the development of excessive sovereign control or ownership of genetic 
material is likely to lead to over-regulation
66
, with bureaucratic red tape impeding important 
genetic research.  
Although UNESCO’s declaration that the human genome in its natural state should not give 
rise to financial gain 
53
, it does not offer any protection over segments of the human genome. 
Many of the developed countries allow for genes that have been isolated, extracted and 
functions determined to become a commodity, gain commercial value and allow for its 
patenting
66
. In South Africa, currents laws, such as the Biodiversity Act
69
, restrict access to 
genetic material for the purpose of acquiring remuneration but its exclusion of human genetic 
material from the Act once again leaves a gap for exploitative means. 
Globally, many of the developing countries such as Mexico, Brazil and India for example 
have in place regulatory guidelines
5,10,66
 that view human genetic material as a natural 
resource based on the concept of Genomic Sovereignty as described above as “the capacity of 
a people, country or nation to own, to control both access and use of samples, data and 
knowledge emanating from genetic material”5(p436).  
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Thus with the awakening of the wealth of genetic data available in their respective countries 
the so-called traditional distinctions in legal understanding between human and non-human 
genetic resources is slowly being eroded, with international bodies calling for amendments to 
the Convention of Biological Diversity to be made that govern access to human genetic 
material as well
64
. 
6.1 What is a patent? 
 
A patent provides inventors, who have undertaken some form of research or experimentation, 
the means to make a financial gain from their invention  for a set period of time (usually 20 
years) thus preventing others from exploiting their invention unless prior consent is given
70
. 
The main objective of a having a patent granted over a specific invention is to be able to 
recoup costs that were involved in creating and testing the invention as well as to make a 
profit though commercialisation. It is therefore assumed to be a justifiable system whereby 
innovation is encouraged and rewarded accordingly.
70,71
 Patenting rights are viewed as 
negative rights such that they restrict public access and control over a product in the form of 
preventing sales, use, distribution or manufacturing without approval of the patent holder
71
.  
While it is understood that a patent holder, should be allowed to recoup his costs from 
research and development initiatives and make a profit as well
71
, the patent system must still 
balance the interest of the public and private sector, such that the benefits enjoyed by the 
patent holder should also filter down to society or more specifically a community for their 
contribution in developing a patentable product
5
. However, the question that remains to be 
answered is whether, the benefits of the patent holder be equal to that which the community 
receives or should the benefits be skewed, if so, how skewed and in who’s favour? 
For the patent holder, the benefits accrued are manifold, with specific interest on economic 
sustainability for companies.
71 
Holding a patent not only allows the patent holder to make 
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money but also provides an incentive and encourages investment in turning acquired 
knowledge through genetic resources into a form of marketable and helpful product.
23
 This 
investment further allows then for greater efforts to be made in the development of other 
products that could benefit a community or society as a whole.  
From a genetic material ownership point of view, those who acquire patents due to genetic 
research involving population groups or communities have a duty to compensate those who 
have contributed to the research and development of that product by their population.
52
 This 
may be in the form of profit sharing, for example where the community may receive are 
certain percentage of all sales for that product; but this may take months or more realistically 
years before any remuneration back to the community can be seen. Thus a patent holder 
should also prior to obtaining a patent in this case, compensate the community involved.
54
 
These are short term benefits, made before a research study can begin and can include the 
research body improving the community’s healthcare facilities or educational resource 
contributions or even providing them with the means to increase their agricultural capacity. It 
is important to note that the benefit obtained from a research body/patent holder to a 
community need not be limited to only things related to healthcare as this may not always be 
the greatest concern for that community. 
For something to be patentable there are criteria which must first be met. Section 25 (1) of the 
Patents Act
72
 states that: “A patent may, subject to the provisions of this section, be granted 
for any new invention which involves an inventive step and which is capable of being used or 
applied in trade or industry or agriculture”. The Act further stipulates that “The duration of a 
patent shall, unless otherwise provided in this Act, be 20 years from the date of application 
…, subject to payment of the prescribed renewal fees by the patentee concerned or an agent’ 
(S 46(1))
72
. Once the patent has expired, the patent holder is required to disclose to the public 
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the invention in full so that the invention can be put into practice as well as the information 
used to increase the public knowledge-base and thus promote further research.
70,71,72
 
 
Therefore: “a patent is a grant of a property right to the inventor of an invention by the 
government acting through the Patent Office …. A patent, like any other form of property, 
can be sold, bought, rented or hired”.73(p87) However, it is important to note that: “Patents are 
territorial rights and a South African patent will only give the holder rights within South 
Africa”.73(p87) 
6.2 Patenting of DNA in Biotechnology 
 
The influx of companies applying for patents of genes or gene segments continues to 
increase. A report issued by the United Nations Development Programme states that 
industrialised countries hold 97% of all patents globally. In addition, 80% of the patents 
granted in developing countries are owned by multi-national companies that belong to the 
industrialised world. It is estimated that only 0.1% of the patents filed by the United States 
Patent and Trademarks Office were by developing countries for a variety of patents, mainly 
in sub-Saharan Africa.
74
 
The risk then in patenting genetic material such as gene sequences is that the exclusive 
ownership of that sequence while relevant to the derived biomedical and genetic findings 
prevents downstream developments of medical treatments and therapeutics based on the 
patented data.
74
 
An example of this is the much cited case involving Myraid Genetics and its patenting and 
licensing of the BRCA1 and BRCA2 genes that have been found to be associated with breast 
and ovarian cancer in women.  In countries, in which the Myraid Genetics patent holds, 
companies and research institutes not affiliated with Myraid could not, without prior 
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permission, perform research that could refine, improve and validate claimed genetic tests, 
nor could they identify new test and diagnostic approaches.
75
 
However on the 13
th
 June 2013 Justice Thomas made a United States Supreme Court ruling 
regarding the patenting of human genes based on the case against Myraid Genetics regarding 
the patents obtained for naturally occurring BRCA genes
76
. It was decided that it was the 
opinion of the court that “we hold that a naturally occurring DNA segment is a product of 
nature and not patent eligible merely because it has been isolated, but that cDNA is patent 
eligible because it is not naturally occurring”(p1). Based on this ruling the patent rights of 
BRCA1 and BRCA2 currently held by Myraid Genetics were lifted thus allowing other 
companies and research institutes where the patent was held to conduct biomedical research 
and diagnostic testing without infringing on patent laws. The court ruling was made by 
determining what constitutes being a “new invention” for biological material such as DNA, 
for which the conclusion of naturally occurring DNA is not eligible to be represented by such 
condition. However the eligibility of complementary DNA (cDNA) as a patentable invention 
was determined on the grounds that “cDNA cannot be isolated from nature, but instead must 
be created in the laboratory . . . because the introns that are found in the native gene are 
removed from the cDNA segment”.76(p10) 
Before a patent can be claimed it is important to distinguish between an invention and a 
discovery, of which the latter cannot be patented. Finding a definition that separates these two 
is difficult but can be commonly distinguished by ‘what exists “in nature”, and what is the 
product of human labour, or at a minimum, human intervention’.75 In the field of 
biotechnology, this distinction becomes a lot more blurred as the content in which such work 
is done on is of “natural” existence. Hence there is much controversy over the patenting of 
DNA (genomes, genes, DNA sequences). 
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According to the United States Patents and Trademark Office (USPTO) “a patent on a gene 
covers the isolated and purified gene but does not cover the gene as it occurs in nature”.76 The 
European Biotechnology Directive 98/44/EC, article 5(2) states that, “an element isolated 
from the human body or otherwise produced by means of a technical process, including the 
sequence or partial sequence of a gene, may constitute a patentable invention; even if the 
structure of that element is identical to that of the natural element”.77 
South Africa is silent with regard to patenting any form of human genetic material. South 
Africa has in place laws, regulations and guidelines such as the Biodiversity Act No. 10 of 
2004
80
 as well as the guidelines for South Africa’s Bioprospecting, Access and Benefit 
Sharing Regulatory Framework issue by the Department of Environmental Affairs
78
. Within 
these laws, issues surrounding patenting of biological resources are mentioned but make 
explicit mention that these laws and guidelines exclude human genetic material. Nonetheless 
extrapolation of relevant information from such legal documents is still relevant in relation to 
human genetic material and thus could be used as a stepping stone in an effort to set into 
motion regulatory legislature for human genetic resources. 
For instance, the Biodiversity Act defines indigenous biological resources as “any living or 
dead animal, plant or other organism of an indigenous species, any derivative of such animal, 
plant or other organism and any genetic material of such animal, plant or other organism”.80 
Despite the exclusion of humans from this Act one does have the option to play with the 
interpretation of this definition. For example, if one considers evolution it is easy to assume 
that humans themselves are animals, given an elevated status based on our cognitive abilities 
to think and analyse before reacting to a situation, but in essence still animals. No greater 
evidence can be found in genetic studies which use various animal models as comparisons to 
humans in identifying homologous genes and deducing their possible function through such 
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association. For example the whole genome sequencing of the Fugu Puffer Fish has helped to 
identify close to 1000 human genes.
79
 
Another extrapolation can be taken from the terms ‘other indigenous species’. Firstly “other 
indigenous species” is not defined in the Act leaving room for interpretation. Thus if one 
chooses not to classify humans under the category of animals then it is by default assumed 
that the species should fall under ‘other’. Secondly, human genetic studies have continuously 
claimed that the indigenous people of southern Africa including South Africa, namely the 
Khoi-San
14
, are our closest link to our most common ancestors
12,14
. 
6.3 South Africa’s Intellectual Property system - Patent Act No. 57 of 
1978 
 
In 2005, section 2 of the Patents Act No. 57 of 1978
72
 was amended to include certain 
definitions as well as stipulating the requirement for an applicant, for a patent, to furnish 
information relating to any role played by an indigenous biological or genetic resource or 
traditional knowledge. Those who wish to file an application to the Patents Office using 
indigenous knowledge, are obligated to disclose their source and thus work out an equitable 
and fair compensation to that relevant community. 
However while this amendment is promulgated, the Act
72
 on its own is still active, as section 
25(1) of the Act states that a patent is granted for any new invention, which involves an 
inventive step and which is capable of being used or applied in trade or industry or 
agriculture. For human genetic material patents, the definition itself poses major challenges. 
a) “Patent is granted for any new invention” 
A specific gene sequence or partial thereof is not novel. Such sequence data has existed prior 
to its scientific investigation thus taking into account the Supreme Court ruling on Myraid 
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Genetics,
76
 DNA isolated in its natural form cannot be patented nor classified as a “new 
invention”.   
b) “Which involves an inventive step” 
This statement implies that something new was created or an inventive step arose out of a 
process. For genetic information such as targeted gene isolation and expression it is difficult 
to prove as such biological processes already occur in nature, whether it be ancestral or 
mutant. Additionally research, that finds evidence of a gene or other genomic data that is or 
could be linked to a specific disease or disorder, constitutes more an event of discovery rather 
than an invention. Furthermore, the scientific theory applied to such a discovery is also not 
eligible for patenting under the condition of an inventive step.
70
 This is justified by the need 
for scientific research to be continuously validated through reproducibility and proven 
robustness of a technique in order to either support or disprove a scientific theory. 
c) “being used in trade or industry or agriculture” 
Generally South African law exclude discoveries, scientific theories and any human or 
animal treatment method including surgery, therapy or diagnostics as patentable inventions. 
Such methods shall not be capable of being used or applied in trade, industry or agriculture if 
patented, but the law would grant a patent to a product consisting of a substance or 
composition being deemed to be capable of being used are applied in trade, industry or 
agriculture, even though it was invented for use in any such method. Hence section 25(1) of 
the Act
72
 does not define what a patent is not, but rather only provides clarification of what is 
cannot be. 
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The Patent Act overall leaves one with a feeling of having missed information relevant to 
genetic resources, but upon review it was found here to general lack of regulation for such 
material. However the amendment requiring disclosure of the use of indigenous knowledge is 
noteworthy as this provides for a means to ensure fair compensation to the relevant 
communities through various acts of benefit sharing. 
6.4 Benefit sharing  
 
Connected to the question of ownership and property and patenting lies the question of how 
those who contribute their genetic material to a study are compensated before collection, 
during the study and at the end of a study. This is known as benefit sharing. 
 
Benefit sharing with regard to research involving genetic material is not adequately provided 
for in the NHA. While S83 of the Biodiversity Act No. 10 of 2004
80
 does offer some form of 
guidance on benefit sharing contracts, by specifying the following conditions: 
83. (1) A benefit-sharing agreement must- 
(a) be in a prescribed format; 
(‘b) specify- 
 (i) the type of indigenous biological resources to which the relevant bioprospecting 
relates; 
(ii) the area or source from which the indigenous biological resources are to be 
collected or obtained; 
iiii) the quantity of indigenous biological resources that is to be collected or obtained 
(iv) any traditional uses of the indigenous biological resources by an indigenous 
community; and 
(v) the present potential uses of the indigenous biological resources; 
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 (c) name the parties to the benefit-sharing agreement;  
(d) set out the manner in which and the extent to which the indigenous biological 
resources are to be utilised or exploited for purposes of such bioprospecting; 
(e) set out the manner in which and the extent to which the stakeholder will share 
in any benefits that may arise from such bioprospecting; 
(fi provide for a regular review of the agreement by the parties as the  
bioprospecting progresses; and 
(g) comply with any other matters that may be prescribed. 
 However, the explicit mention that the Act does not include biological samples of human 
origin makes it difficult to use as a means of protective legislature within human genomic 
research. Hence there appears to be a regulatory vacuum within the context of genomic 
research in relation to ownership (sample and data) with regard to samples of human origin. 
This therefore leaves room for acts of bioprospecting and biopiracy to continue within the 
country without a proper means of repudiation. 
6.5 Legal conclusion: Ownership and property 
 
From a sovereignty point of view, without a clear definition with regard to human tissue, it 
becomes difficult to impose such a right over genetic material bearing in mind that all 
biological material obtained from a person is of potential genetic worth. Furthermore 
Mahomed et al mentions that “Although South African legislation seems to adequately deal 
with the issue of informed consent for the removal of human biological material from living 
and deceased persons for research purpose, informed consent relating to the participation in 
the research should be distinguished from specific consent relating to the future use of the 
human biological material. This is an issue that is often over-looked”.81(p17) 
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In a study Nienaber
82
 addresses the issue of consent and authorisation of human tissues after 
its primary use in research. Her findings lead to the conclusion that despite the existence of 
international Research Ethics documents and conventions governing the future use of human 
biological materials, “South Africa’s framework does not address informed consent for the 
future use of human biological material, unlike other African countries like Nigeria and 
Kenya”.81(p17)82 In relation to ownership and property rights this leaves little if any possible 
legal regulation for such samples if control over them is not determined at the beginning. 
Thus if sovereignty is to be achieved then these t/issues need to be dealt with first 
beforehand. Future use of these samples outside the scope of the primary study must be 
included in the proposal for ethics clearance as well as being included as part of the informed 
consent processes. In this way, protection for people contributing to these studies is protected 
and future benefits from other studies utilising these sample sets can be secured. 
Sovereignty essentially stands for being able to hold final decision making power in a system 
of government, thus by extension, genomic sovereignty would imply the same description 
with regard to genomic material. However for natural flora and fauna assigning sovereign 
rights is less complicated
83
 as opposed to genetic material of human origin which is often 
debatable between that of national governments and the people/communities of that area. The 
assumption made usually is that national government exclusively is the best option to protect 
the interests of its population groups within its borders. 
To reiterate, according to South African law at present everyone has a right to their own body 
as a whole, pertaining to freedom of the persons
58
; once biological material has been 
separated from its source, authority over that material becomes ambiguous especially with 
regard to ethnic indigenous groups. These communities are representative of people whom 
have chosen not to be associated with the current, modern and primarily western running’s of 
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the world today.
84
 From a genetics point of view, this makes them a valued ‘asset’ as they are 
viewed as valuable genetic resources that have been untainted by today’s physical and 
environmental stresses of life. Therefore when such a population group displays a certain 
disease or characteristic that could benefit all of humanity through research purposes, they 
become prime genetic material resource targets. 
These indigenous peoples, owing to their choice not to conform to modern society,
84
 in turn 
place themselves at risk of submitting to having these genetic tests done without a clear scale 
of the potential impact it may have on such a community, both positively in the form of 
benefits and negatively through studies that may contradict traditional and cultural belief 
systems of those communities. Researchers may play on this vulnerability, reducing the study 
to a notion in which the community is viewed as objects of curiosity rather than forming a 
relationship with the research participants. Evidence of such things happening to indigenous 
populations is illustrated by the controversial genomic research that was conducted on the 
Havasupai Indians by the University of Arizona.
85
 
 Ethnicity stands ill-defined. Such that it is defined as ‘relating to a population subgroup 
(within a larger or dominant natural or cultural group) with a common national or cultural 
tradition,
86
 further relating to ‘national and cultural origins’ is defining for example a 
population based on linguistics or by ‘denoting origin by birth or descent rather than by 
present nationality’86 
To add to this, there is the issue of self-identification and the creation of new groups that 
emerge due to changing socio-economic developments
47
. For example, an Indian person born 
in South Africa has various ways to identify himself. He could be considered an African, 
been born on this continent or Indian South African on a national scale or even South African 
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of Indian descent. Each of these are functionally acceptable to the individual but can cause 
greater misinterpretation of genetic data due to self-classification and ethnicity. 
Another challenge that faces the concept of genomic sovereignty is that of ethnicity across 
boundaries. For example, on a ‘local’ scale the San people of Southern Africa are a 
population spread over three boundaries, namely, South Africa, Namibia and Botswana
47
. On 
an international scale there are those individuals having ancestry linked to the African 
continent that were taken across to the Unites States of America and Europe during the years 
of colonialism and slavery. In these cases sovereignty over genomic material seems difficult 
to attain, such that access to individuals of a specific group can always be found in another 
country with less restriction and regulation. It therefore seems that if the concept of genomic 
sovereignty is to be promulgated into any type of protective law then such law needs to be 
agreed upon by all countries in order to protect those populations groups. Without such 
collaboration genomic sovereignty as a law in a specific nation seems fruitless against any 
measure of bioprospecting.
46,47
 
Thus if one looks at the regulations associated to the NHA with regard to this issue, it appears 
that current regulations and legislature paint a picture that denotes an ideal that relates more 
to the Common Heritage Concept. Evidence within the regulations mentioned above attempt 
to provide protection of population groups, whilst their genetic material is still freely 
available to leave South Africa with little or no benefit to them
31
. Thus leaves room for 
speculation that researchers of the developed world may choose to do research in a less 
developed country to obtain samples that have better use in a greater research study on the 
developed side of the world. While this may seem a bit over imaginative, the possibility in 
hindsight for such events occurring from all research done in less developed countries does 
exist if one considers Nienabers’ report82with regard to future use of human biological 
material. 
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7. Blurring the lines: The common-sovereignty 
compromise approach 
 
Common heritage describes that genetic material like other common resources should always 
be shared, that it is excluded from privatisation and sovereignty, thus being made available 
for scientific research initiatives. But these genetic materials such as genetically modified 
organisms and human genetic material are being sifted through and absorbed into privately 
owned entities and/or sovereign nation states. The justification for these occurrences is 
attributed to biodiversity conservation. This is apparent in the International Convention on 
Biodiversity, which provides more for a nation state to apply sovereign rights over their 
natural resources. Thus the question then is, for samples of human genetic material, how can 
these concepts of common heritage and genomic sovereignty together with the ideals of 
intellectual property, namely patenting work in a collaborative and mutually beneficial way?  
The first approach is to down scale the level at which common heritage is applied so that it 
can fit in with that of genomic sovereignty ideals. The way this can be achieved is to look 
more locally with regard to heritage. It is understandable that we are all human beings of the 
same earth living on different pieces of land separated by mountains, valleys, deserts, rivers 
and seas and it is to that degree of separation that populations localise their culture and 
traditional identities and knowledge systems. Therefore to each of these communities there is 
a shared heritage amongst themselves irrespective of their existence to the global community 
that they also belong to. Therefore genomic sovereignty can be employed to protect the local 
and indigenous heritage of a people within a land. 
The second approach aims to look at the way human genetic material is regarded within both 
concepts. Both the common heritage concept and genomic sovereignty provide clear 
understanding that when dealing with human genetic material, such material removed from 
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the human body still maintains intrinsic worth. Thus if such material is capable of 
commodification that can be accessed by all, either through the common heritage concept 
ideals of universal sharing or through genomic sovereignty legislation granting access, then 
such a commodity can no longer be regarded as heritable but rather as a resource for common 
use.  
It is interesting to note that even as a ‘common resource’ the guidelines of genomic 
sovereignty in its ability to control access to the human genetic material of that nation 
consequently provides a level of protection to such resources deemed common heritage under 
the assumption of the first approach, localising common heritage. 
Based on the two approaches mentioned above it is noticeable that although the common 
heritage concept and genomic sovereignty are generally said to have opposing views with 
regard to human genetic material, there are levels of commonality that could allow them to 
work together. Hence the common-sovereignty compromise approach aims to utilise these 
levels of commonality in efforts to provide a global service (common) with regard to 
genomic research as well as national security (sovereign) by protecting its people from 
exploitation though bio-prospecting and bio-piracy thereby ensuring justifiable research 
agendas and benefits be negotiated.  
The common-sovereignty compromise approach objectives are firstly to provide for 
ownership of human genetic material to reside at all times with the people from whom such 
samples are collected from a defined land, such as, a village or local town . This allows for 
better control over the type of research that can be undertaken with the population specific 
identifiable materials and data. Secondly, I propose that the responsibility for controlling 
access to and use of samples and data be devolved to the research institutions in the collection 
thereof, in a stewardship or custodian model
52
. This fits in nicely with the research guidelines 
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that allow a person, in this case their genetic material, to withdraw from a study without 
prejudice.
6
 Thus research, based on the agreement between the research body and the 
population involved, may either require the materials be destroyed or returned to the 
population group depending on cultural belief systems. 
It should be noted that the common-sovereignty compromise approach is only valid for 
genetic material and data that contains identifiable data and information linking it to a nation 
state or specific population group. Should the research body indicate that the samples and 
data gathered will be anonymous, ownership rights to those samples by the population asked 
to provide it are no longer valid. This type of approach is valid for studies that employ a 
‘double blind’ approach to their study, whereby the research body may have a disease or 
disorder in question which they would like investigate further but enter the study with a blind 
approach as to what may be the cause other than the idea of a few candidate genes. Then 
random sampling of populations to further investigate those genes is possible provided it 
remains anonymous. This is equivalent to studies involving ‘demic’ populations19 as 
explained in the group ownership and genomic sovereignty section above.  
The common-sovereignty compromise approach overall provides for the possibility of 
ownership to be interpreted in more than one way, as opposed to the common heritage 
concept that can be regarded as too broad or genomic sovereignty that can be associated as 
sometimes being too restrictive. The common-sovereignty compromise approach provides the 
option of flexibility and therefore leaves room for compromise with regard to ownership of 
human genetic material. 
Therefore the common-sovereignty compromise approach provides for 3 levels of ownership 
possibilities, that is, 1) exclusive ownership of human genetic material by a people within a 
nation state, 2) shared ownership between a people and research body in which researchers 
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are limited to certain ownership rights regulated by the terms of used agreed upon by a people 
or nation and 3) complete ownership of human genetic material by researchers provided all 
demographic information linking it to a specific population is erased and/or destroyed. 
Furthermore the common-sovereignty compromise approach aims to incorporate a collective 
property approach with regard to deciding how a peoples resources in a nation, state should 
be used, as opposed to common property, which within a given area is state determined and 
controlled.  
For a group of people to have collective ownership over their genetic heritage, one must 
consider the reasoning behind conducting a focused study on a specific population. The issue 
of collective heritage brings to light the definition of genomic sovereignty. For example the 
Canadian Institute for Health Research (CIHR)
52
 issued guidelines for health research 
involving aboriginal peoples. The guideline recommends co-ownership of both sample and 
data generated between the aboriginal people of that area and the researchers involved. These 
guidelines advocate that samples contributed to a study should be considered ‘on loan’ to the 
researcher unless otherwise specified in the research agreement, invoking a state of 
stewardship over those samples by the researchers involved. These guidelines also provide 
for a special protection for indigenous peoples cultural and sacred knowledge. This 
knowledge type although not explicitly mentioned can be used to infer the notion of 
collective ownership over genomic samples and data. 
Following from these guidelines, the common-sovereignty compromise approach ensures that 
although a nation, state will protect its people from bioprospecting and bio-piracy that nation 
governance cannot coerce its people to participate in any form of study including genetic 
research if they choose not to. In this way the people’s autonomy and respect for persons is 
maintained and prevents a government from taking a more autocratic approach whilst making 
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the assumption that such research is something that the people of that nation are willing to 
agree to without proper consultation, as this can been seen as a violation of rights based 
ethics – right to privacy. 
Furthermore indigenous populations are fairly homogenous in their genetic makeup as well as 
small in number. This places them as a vulnerable group subject to certain group harms. 
Specifically with regard to the issue of ‘patented DNA’. The act of patency can lead to the 
exploitation of a peoples genetic heritage thus highlighting the issue of non-maleficence by 
invoking a social harm to these people by simply removing or disregarding their humanity in 
terms of who they are as a community as well as what makes them so culturally distinct. This 
could render them or part of them (genetic material) as a mere commodity item that can be 
used for commercial gain or other research without benefit to that population. 
The statement above pertains to the risks involved in patenting DNA at a population or group 
level. Although this is of significant value and must be addressed accordingly, there is 
another side for which patency poses a problem. This is at the institutional level, where 
research on genes can be stifled due to companies in that area holding patent rights over that 
gene. Thus the third approach is to provide genomic information on an open source network. 
In this way the distribution of human genetic material is shared equally by all of those who 
wish to make use of it. For example, the SNP Consortium, which is a project dedicated to 
elucidating and providing the global scientific community with information of DNA 
sequence variation within genomes and in providing this information freely entered into an 
agreement not to patent their sequence maps.
87
 Another example of open source information 
sharing is Alfred Gillman’s ‘Cellular Signalling’ project.88 
What makes both these projects noteworthy is that they are both open source information 
centres that are supported institutionally and financially by major institutions in genomics, 
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such as the National Institute of Health (NIH) as well as large corporations in biotechnology, 
such as, Eli Lilly, Merck, Aventis, Johnson & Johnson and Novartis. The Cellular Signalling 
initiative is further supported by international scientific journal Nature.
88 
Interestingly, the 
biotech firms associated with these initiatives allow for copyleft policy, that is, allow access 
to the information generated by these two projects, freely.
89
 The objective of the copyleft 
approach demonstrates the notion of altruism by providing genomic data with no actual 
return to the project except for the desire that other researchers like themselves follow 
through with this act of altruism and share their genomic data with everyone as well, 
invoking a state of commons. Gillman’s cellular signalling project goes even further with 
regard to open source by not only providing information but also modelling quantitative 
virtual cells by interactive peer reviews of genetic information outside journals or patents.
89
  
Thus it becomes fairly noticeable that contributors, specifically those of the biotech industry 
aren’t completely interested in just acquiring financial dividends or patents rights over 
sequence variations.
89
 It is more likely that economic gain for these stakeholders are to be 
acquired through alternative means, such as, patents of products derived from sequence 
variation data as well as marketing and sales of those products. 
Providing genomic information in an open source network thus provides a means to share 
genomic information with fellow researchers while still allowing acts of patency to continue 
on products derived from its information but not on the genomic data itself. Furthermore, in 
the age of technological advancement, providing genomic information through electronic 
means ensures that the actual samples remain locally retained, respecting a community’s right 
not to have their DNA samples exported without consent. This approach also provides a 
means to anonymise the data being released, further protecting both a community and person. 
Lastly, should information about the data be requested that is of an identifiable nature, its 
release can be locally controlled at the institutional level but determined at the community 
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and individual level. Therefore the dissemination of information and what type of 
information can and cannot be released provides a method of maintaining the control of their 
genomic information. Communities are therefore able to actively determine the access and 
benefit sharing agreements between researcher and nation-community. 
With regard to benefits, between the concept of common heritage, genomic sovereignty and 
the common-sovereignty compromise approach, the distribution of knowledge is regarded as 
a global benefit that should be universally distributed. However other benefits should be 
evaluated based in the contribution to research and the level of necessity to that nation. For 
example, a developed nation may choose financial rewards for their contribution to research, 
whereas those of the developing world may opt for technology transfers, access to other 
resources or aid in development of healthcare and education infrastructure in that state. 
It is important to note that this ‘end point’ benefit option is aimed at a national level for 
which the nation receiving such benefits is to be held responsible for its distribution and use 
locally. The research group when working with a population must prior to beginning the 
study define the type and level of benefits that a population will receive before, during and 
after a study as stipulated within bioethical guidelines. 
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8. Conclusion 
 
Ownership with regard to human genetic material provides for discourse that is both complex 
and fairly unsettled. For the last three decades or so there has been a shift in thinking towards 
resources considered common heritage to humanity to it becoming an item of appropriation 
and commodification that is subject to intellectual property rights and national sovereignty. 
This shift has led to efforts to protect against exploitation of peoples for their genetic 
resources but has also lead to unequal sharing and access to these resources such as genomic 
material, information and biotechnology. Ownership further highlights the disparities 
between developed and developing countries as well as those between national governments 
and its people, more specifically its indigenous people, with regard to access to these 
genomic samples and information, levels of intended use and benefit agreements. 
To argue one concept over another seems fruitless when the end result for the common 
heritage concept and genomic sovereignty are the same. These are to conduct good research 
in human genetics whilst still providing a common good to the people involved and overall 
create a benefit to all mankind. Thus a blended approach of these two concepts would appear 
of greater use by using the commonalities of both concepts to work through their differences.  
Moreover the question of ownership of genetic material undoubtedly raises the need for re-
evaluation of how the concept of property is understood, interpreted and defined with regard 
to human genetic material. This in turn should provide a link between open source data and 
biotechnology as well as genomics as a whole with humanitarian objectives. Therefore the 
potential to re-negotiate and re-design biotechnology with regard to human genetic material 
and information does exist through a means of an open source approach.  
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The common-sovereignty compromise approach presented in this research aims to provide a 
foundation that exemplifies an ‘access to all’ understanding, whereby one cannot claim 
exclusive ownership, but also prevents others from claiming the same and to ensure that 
should revenue be made off these genetic material, that there is a framework for distribution 
of those resources. It must however be noted that the common-sovereignty compromise 
approach is merely a concept upon which  myself and others may use to build upon so as to 
further investigate and draw our own conclusions towards the issues of ownership of human 
genetic material. Thus further investigation into this approach is necessary in efforts to 
further develop it, something that could not be done due the size limitation of this research 
report. 
Therefore this normative analysis of the concept of ownership is important as various ethical 
guidelines and legal regulations need to be further developed and entered into socio-
economic and political discourse with greater vigour, so as to provide a sound framework 
from which to address issues associated with genomic research- such as ownership, access 
and benefit sharing, as they arise in the practical aspects of genomic research, in regard to 
sample collection, data generated and commercialisation.  
It is without dispute that for any genetic research to be done or development of some 
therapeutic measure to be implemented, sample donation of biological/bodily or DNA 
samples are imperative. However, in knowing this, the ethical questions involved in such 
research initiatives still need to be addressed in greater depth. The views, statements and 
recommendations made in this research report are an attempt to highlight the surrounding 
concerns mentioned above as an essential aspect of research to ensure that  scientific integrity 
be maintained and that human intrinsic value and worth be respected at all times. If these two 
aspects can be made to work together in a mutually beneficial state, it may then make genetic 
research initiatives appear less inimical to individuals. Once the shroud of the unknown is 
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made clear it is with hope that participants will feel safe, comfortable and secure and thereby 
more willing to participate in such research. 
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